{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T22:50:31Z","timestamp":1789426231281,"version":"build-2803163510"},"reference-count":575,"publisher":"The Endocrine Society","issue":"5","funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,9,15]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Recent data suggest an increase in the overall incidence of parathyroid disorders, with primary hyperparathyroidism (PHPT) being the most prevalent parathyroid disorder. PHPT is associated with morbidities (fractures, kidney stones, chronic kidney disease) and increased risk of death. The symptoms of PHPT can be nonspecific, potentially delaying the diagnosis. Approximately 15% of patients with PHPT have an underlying heritable form of PHPT that may be associated with extraparathyroidal manifestations, requiring active surveillance for these manifestations as seen in multiple endocrine neoplasia type 1 and 2A. Genetic testing for heritable forms should be offered to patients with multiglandular disease, recurrent PHPT, young onset PHPT (age \u226440 years), and those with a family history of parathyroid tumors. However, the underlying genetic cause for the majority of patients with heritable forms of PHPT remains unknown. Distinction between sporadic and heritable forms of PHPT is useful in surgical planning for parathyroidectomy and has implications for the family. The genes currently known to be associated with heritable forms of PHPT account for approximately half of sporadic parathyroid tumors. But the genetic cause in approximately half of the sporadic parathyroid tumors remains unknown. Furthermore, there is no systemic therapy for parathyroid carcinoma, a rare but potentially fatal cause of PHPT. Improved understanding of the molecular characteristics of parathyroid tumors will allow us to identify biomarkers for diagnosis and novel targets for therapy.<\/jats:p>","DOI":"10.1210\/endrev\/bnad009","type":"journal-article","created":{"date-parts":[[2023,3,24]],"date-time":"2023-03-24T17:16:47Z","timestamp":1679678207000},"page":"779-818","source":"Crossref","is-referenced-by-count":58,"title":["Molecular and Clinical Spectrum of Primary Hyperparathyroidism"],"prefix":"10.1210","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9201-3340","authenticated-orcid":false,"given":"Smita","family":"Jha","sequence":"first","affiliation":[{"name":"Metabolic Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health , Bethesda, MD 20892-1752 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7806-706X","authenticated-orcid":false,"given":"William F","family":"Simonds","sequence":"additional","affiliation":[{"name":"Metabolic Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health , Bethesda, MD 20892-1752 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2023,3,24]]},"reference":[{"issue":"2","key":"2023091509045933600_bnad009-B1","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S0021-9258(18)84940-7","article-title":"Further studies on the physiological action of a parathyroid hormone","volume":"64","author":"Collip","year":"1925","journal-title":"J Biol Chem"},{"issue":"4","key":"2023091509045933600_bnad009-B2","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1073\/pnas.67.4.1862","article-title":"Bovine parathyroid hormone: amino acid sequence","volume":"67","author":"Brewer HB","year":"1970","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"2023091509045933600_bnad009-B3","first-page":"1586","article-title":"The amino acid sequence of bovine parathyroid hormone I","volume":"351","author":"Niall","year":"1970","journal-title":"Hoppe Seylers Z Physiol Chem"},{"issue":"7","key":"2023091509045933600_bnad009-B4","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1177\/014556139607500713","article-title":"Parathyroid update: a review of 220 cases","volume":"75","author":"Summers","year":"1996","journal-title":"Ear Nose Throat J"},{"issue":"5","key":"2023091509045933600_bnad009-B5","first-page":"814","article-title":"The anatomy of primary hyperparathyroidism","volume":"92","author":"Thompson","year":"1982","journal-title":"Surgery"},{"issue":"8","key":"2023091509045933600_bnad009-B6","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1001\/archsurg.1989.01410080041006","article-title":"The reasons for failure in parathyroid operations","volume":"124","author":"Levin","year":"1989","journal-title":"Arch Surg"},{"issue":"1","key":"2023091509045933600_bnad009-B7","first-page":"14","article-title":"Surgical anatomy of human parathyroid glands","volume":"95","author":"Akerstrom","year":"1984","journal-title":"Surgery"},{"issue":"2","key":"2023091509045933600_bnad009-B8","first-page":"120","article-title":"Cause and current management of reoperative hyperparathyroidism","volume":"59","author":"Carter","year":"1993","journal-title":"Am Surg"},{"key":"2023091509045933600_bnad009-B9","first-page":"37","volume-title":"The Parathyroids, Basic and Clinical Concepts","author":"Mannstadt","year":"2015","edition":"3rd ed."},{"issue":"3","key":"2023091509045933600_bnad009-B10","first-page":"685","article-title":"Estimation of the parathyroid parenchymal cell mass by density gradients","volume":"99","author":"Akerstrom","year":"1980","journal-title":"Am J Pathol"},{"issue":"3","key":"2023091509045933600_bnad009-B11","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/path.1711280303","article-title":"The normal parathyroid gland at autopsy: the significance of stromal fat in adult patients","volume":"128","author":"Dekker","year":"1979","journal-title":"J Pathol"},{"issue":"8","key":"2023091509045933600_bnad009-B12","doi-asserted-by":"crossref","first-page":"3092","DOI":"10.1073\/pnas.1319742111","article-title":"Functional and genetic studies of isolated cells from parathyroid tumors reveal the complex pathogenesis of parathyroid neoplasia","volume":"111","author":"Shi","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"2023091509045933600_bnad009-B13","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0046-8177(82)80293-1","article-title":"The normal parathyroid revisited: percentage of stromal fat","volume":"13","author":"Dufour","year":"1982","journal-title":"Hum Pathol"},{"issue":"4","key":"2023091509045933600_bnad009-B14","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1159\/000147082","article-title":"Origin of the water-clear cell in the parathyroid gland of the golden hamster","volume":"140","author":"Emura","year":"1991","journal-title":"Acta Anat (Basel)"},{"issue":"3","key":"2023091509045933600_bnad009-B15","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1080\/07435800.2018.1437747","article-title":"MIBI scintigraphy of parathyroid adenomas: correlation with biochemical and histological markers","volume":"43","author":"Cordes","year":"2018","journal-title":"Endocr Res"},{"issue":"8","key":"2023091509045933600_bnad009-B16","doi-asserted-by":"crossref","first-page":"E1499","DOI":"10.1210\/jc.2011-3366","article-title":"Differential gene expression by oxyphil and chief cells of human parathyroid glands","volume":"97","author":"Ritter","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2023091509045933600_bnad009-B17","first-page":"271","article-title":"Surgical anatomy of the parathyroid glands in secondary hyperparathyroidism","volume":"43","author":"Butterworth","year":"1998","journal-title":"J R Coll Surg Edinb"},{"issue":"1","key":"2023091509045933600_bnad009-B18","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3109\/00365598409182168","article-title":"Histological changes in parathyroid glands in subclinical and clinical renal disease. An autopsy investigation","volume":"18","author":"Akerstrom","year":"1984","journal-title":"Scand J Urol Nephrol"},{"issue":"2","key":"2023091509045933600_bnad009-B19","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3109\/00365598409182184","article-title":"Parathyroid pathology in hyperparathyroidism secondary to chronic renal failure","volume":"18","author":"Malmaeus","year":"1984","journal-title":"Scand J Urol Nephrol"},{"issue":"2","key":"2023091509045933600_bnad009-B20","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1002\/dc.24338","article-title":"Application of GATA 3 and TTF-1 in differentiating parathyroid and thyroid nodules on cytology specimens","volume":"48","author":"Shi","year":"2020","journal-title":"Diagn Cytopathol"},{"issue":"1","key":"2023091509045933600_bnad009-B21","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/PAS.0b013e31820371e4","article-title":"Study of parathyroid transcription factor Gcm2 expression in parathyroid lesions","volume":"35","author":"Nonaka","year":"2011","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"2023091509045933600_bnad009-B22","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1007\/s12022-019-9578-3","article-title":"Parathyroid neoplasms: immunohistochemical characterization and long noncoding RNA (lncRNA) expression","volume":"30","author":"Yu","year":"2019","journal-title":"Endocr Pathol"},{"issue":"4817","key":"2023091509045933600_bnad009-B23","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1126\/science.3616618","article-title":"A parathyroid hormone-related protein implicated in malignant hypercalcemia: cloning and expression","volume":"237","author":"Suva","year":"1987","journal-title":"Science"},{"issue":"3","key":"2023091509045933600_bnad009-B24","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1101\/gad.8.3.277","article-title":"Lethal skeletal dysplasia from targeted disruption of the parathyroid hormone-related peptide gene","volume":"8","author":"Karaplis","year":"1994","journal-title":"Genes & development"},{"issue":"1","key":"2023091509045933600_bnad009-B25","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1152\/physrev.1996.76.1.127","article-title":"Defining the roles of parathyroid hormone-related protein in normal physiology","volume":"76","author":"Philbrick","year":"1996","journal-title":"Physiol Rev"},{"issue":"11","key":"2023091509045933600_bnad009-B26","doi-asserted-by":"crossref","first-page":"3539","DOI":"10.1242\/dev.121.11.3539","article-title":"Overexpression of parathyroid hormone-related protein or parathyroid hormone in transgenic mice impairs branching morphogenesis during mammary gland development","volume":"121","author":"Wysolmerski","year":"1995","journal-title":"Development"},{"issue":"3","key":"2023091509045933600_bnad009-B27","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1073\/pnas.91.3.1133","article-title":"Overexpression of parathyroid hormone-related protein in the skin of transgenic mice interferes with hair follicle development","volume":"91","author":"Wysolmerski","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"20","key":"2023091509045933600_bnad009-B28","doi-asserted-by":"crossref","first-page":"11846","DOI":"10.1073\/pnas.95.20.11846","article-title":"Parathyroid hormone-related protein is required for tooth eruption","volume":"95","author":"Philbrick","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"2023091509045933600_bnad009-B29","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1074\/jbc.271.2.1200","article-title":"Overexpression of parathyroid hormone-related protein in the pancreatic islets of transgenic mice causes islet hyperplasia, hyperinsulinemia, and hypoglycemia","volume":"271","author":"Vasavada","year":"1996","journal-title":"J Biol Chem"},{"issue":"4","key":"2023091509045933600_bnad009-B30","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1113\/expphysiol.1990.sp003437","article-title":"Stimulation of ovine placental transport of calcium and magnesium by mid-molecule fragments of human parathyroid hormone-related protein","volume":"75","author":"Care","year":"1990","journal-title":"Exp Physiol"},{"issue":"4833","key":"2023091509045933600_bnad009-B31","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1126\/science.3685995","article-title":"Parathyroid hormone-related protein of malignancy: active synthetic fragments","volume":"238","author":"Kemp","year":"1987","journal-title":"Science"},{"issue":"10","key":"2023091509045933600_bnad009-B32","doi-asserted-by":"crossref","first-page":"3561","DOI":"10.1210\/jc.2014-1413","article-title":"Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the Fourth International Workshop","volume":"99","author":"Bilezikian","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2023091509045933600_bnad009-B33","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1111\/j.1365-2265.2011.04021.x","article-title":"Nontruncated amino-terminal parathyroid hormone overproduction in two patients with parathyroid carcinoma: a possible link to HRPT2 gene inactivation","volume":"74","author":"Caron","year":"2011","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"2023091509045933600_bnad009-B34","doi-asserted-by":"crossref","first-page":"64","DOI":"10.3803\/EnM.2020.35.1.64","article-title":"Rare PTH gene mutations causing parathyroid disorders: a review","volume":"35","author":"Lee","year":"2020","journal-title":"Endocrinol Metab (Seoul)"},{"key":"2023091509045933600_bnad009-B35","first-page":"45","volume-title":"The Parathyroids, Basic and Clinical Concepts","author":"Suva","year":"2015","edition":"3rd ed."},{"key":"2023091509045933600_bnad009-B36","first-page":"65","volume-title":"The Parathyroids, Basic and Clinical Concepts","author":"Gardella","year":"2015","edition":"3rd ed."},{"issue":"5034","key":"2023091509045933600_bnad009-B37","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1126\/science.1658941","article-title":"A G protein-linked receptor for parathyroid hormone and parathyroid hormone-related peptide","volume":"254","author":"Juppner","year":"1991","journal-title":"Science"},{"issue":"6436","key":"2023091509045933600_bnad009-B38","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1126\/science.aav7942","article-title":"Structure and dynamics of the active human parathyroid hormone receptor-1","volume":"364","author":"Zhao","year":"2019","journal-title":"Science"},{"issue":"December 13","key":"2023091509045933600_bnad009-B39","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/1471-2148-6-108","article-title":"Evolution of secretin family GPCR members in the metazoa","volume":"6","author":"Cardoso","year":"2006","journal-title":"BMC Evol Biol"},{"issue":"5","key":"2023091509045933600_bnad009-B40","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1016\/j.bone.2011.02.004","article-title":"Parathyroid hormone 1 (1-34) acts on the scales and involves calcium metabolism in goldfish","volume":"48","author":"Suzuki","year":"2011","journal-title":"Bone"},{"issue":"July 6","key":"2023091509045933600_bnad009-B41","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/1471-2148-12-110","article-title":"Functional characterization and evolution of PTH\/PTHrP receptors: insights from the chicken","volume":"12","author":"Pinheiro","year":"2012","journal-title":"BMC Evol Biol"},{"issue":"May 1","key":"2023091509045933600_bnad009-B42","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/1471-2148-8-129","article-title":"The repertoire of G protein-coupled receptors in the sea squirt Ciona intestinalis","volume":"8","author":"Kamesh","year":"2008","journal-title":"BMC Evol Biol"},{"issue":"2","key":"2023091509045933600_bnad009-B43","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1530\/JOE-10-0439","article-title":"Evolution of the vertebrate pth2 (tip39) gene family and the regulation of PTH type 2 receptor (pth2r) and its endogenous ligand pth2 by hedgehog signaling in zebrafish development","volume":"211","author":"Bhattacharya","year":"2011","journal-title":"J Endocrinol"},{"issue":"1","key":"2023091509045933600_bnad009-B44","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s41574-018-0115-0","article-title":"The calcium-sensing receptor in physiology and in calcitropic and noncalcitropic diseases","volume":"15","author":"Hannan","year":"2018","journal-title":"Nat Rev Endocrinol"},{"issue":"4","key":"2023091509045933600_bnad009-B45","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1210\/er.2018-00126","article-title":"Skeletal and extraskeletal actions of vitamin d: current evidence and outstanding questions","volume":"40","author":"Bouillon","year":"2019","journal-title":"Endocr Rev"},{"issue":"10","key":"2023091509045933600_bnad009-B46","doi-asserted-by":"crossref","first-page":"E2022","DOI":"10.1210\/jc.2012-1340","article-title":"Mutation of the CYP2R1 vitamin D 25-hydroxylase in a Saudi Arabian family with severe vitamin D deficiency","volume":"97","author":"Al Mutair","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"2023091509045933600_bnad009-B47","doi-asserted-by":"crossref","first-page":"E1005","DOI":"10.1210\/jc.2015-1746","article-title":"CYP2R1 mutations impair generation of 25-hydroxyvitamin D and cause an atypical form of vitamin D deficiency","volume":"100","author":"Thacher","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"December 18","key":"2023091509045933600_bnad009-B48","first-page":"F1000 Faculty Rev-1472","article-title":"FGF23 as a calciotropic hormone","volume":"4","author":"Rodriguez-Ortiz","year":"2015","journal-title":"F1000Res"},{"issue":"3","key":"2023091509045933600_bnad009-B49","doi-asserted-by":"crossref","first-page":"e0230130","DOI":"10.1371\/journal.pone.0230130","article-title":"Epidemiology and management of parathyroid gland disorders in Spain over 15 years: a retrospective multicentre analysis","volume":"15","author":"Darba","year":"2020","journal-title":"PLoS One"},{"issue":"Apr","key":"2023091509045933600_bnad009-B50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bone.2014.12.003","article-title":"Secular trends in the incidence of primary hyperparathyroidism over five decades (1965-2010)","volume":"73","author":"Griebeler","year":"2015","journal-title":"Bone"},{"issue":"6","key":"2023091509045933600_bnad009-B51","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1210\/jc.2008-2291","article-title":"Clinical review: Prevalence and incidence of endocrine and metabolic disorders in the United States: a comprehensive review","volume":"94","author":"Golden","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2023091509045933600_bnad009-B52","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1210\/jc.2012-4022","article-title":"Incidence and prevalence of primary hyperparathyroidism in a racially mixed population","volume":"98","author":"Yeh","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"2023091509045933600_bnad009-B53","doi-asserted-by":"crossref","first-page":"4631","DOI":"10.1210\/jc.2012-2484","article-title":"Evidence of a functional estrogen receptor in parathyroid adenomas","volume":"97","author":"Haglund","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2023091509045933600_bnad009-B54","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3390\/cells8010015","article-title":"A role for circular non-coding RNAs in the pathogenesis of sporadic parathyroid adenomas and the impact of gender-specific epigenetic regulation","volume":"8","author":"Yavropoulou","year":"2018","journal-title":"Cells"},{"issue":"6","key":"2023091509045933600_bnad009-B55","doi-asserted-by":"crossref","first-page":"e2215396","DOI":"10.1001\/jamanetworkopen.2022.15396","article-title":"Analysis of comorbidities, clinical outcomes, and parathyroidectomy in adults with primary hyperparathyroidism","volume":"5","author":"Axelsson","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"6","key":"2023091509045933600_bnad009-B56","doi-asserted-by":"crossref","first-page":"812","DOI":"10.7326\/M21-4416","article-title":"Mortality and morbidity in mild primary hyperparathyroidism: results from a 10-year prospective randomized controlled trial of parathyroidectomy versus observation","volume":"175","author":"Pretorius","year":"2022","journal-title":"Ann Intern Med"},{"issue":"May","key":"2023091509045933600_bnad009-B57","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.bone.2014.12.067","article-title":"Mortality associated with primary hyperparathyroidism","volume":"74","author":"Clifton-Bligh","year":"2015","journal-title":"Bone"},{"issue":"1","key":"2023091509045933600_bnad009-B58","first-page":"1","article-title":"Incidence of multiglandular disease in sporadic primary hyperparathyroidism","volume":"10","author":"Vandenbulcke","year":"2014","journal-title":"B-ENT"},{"issue":"1","key":"2023091509045933600_bnad009-B59","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/s12022-022-09709-1","article-title":"Overview of 2022 WHO classification of parathyroid tumors","volume":"33","author":"Erickson","year":"2022","journal-title":"Endocr Pathol"},{"issue":"July 15","key":"2023091509045933600_bnad009-B60","first-page":"3745239","article-title":"The clinical features of cystic parathyroid adenoma in Chinese population: a single-center experience","volume":"2018","author":"Hu","year":"2018","journal-title":"Int J Endocrinol"},{"issue":"July 15","key":"2023091509045933600_bnad009-B61","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.mce.2017.10.001","article-title":"Molecular profiles of oxyphilic and chief cell parathyroid adenoma","volume":"470","author":"Lu","year":"2018","journal-title":"Mol Cell Endocrinol"},{"issue":"2","key":"2023091509045933600_bnad009-B62","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1007\/s12022-020-09616-3","article-title":"Lipoadenoma of the parathyroid gland: characterization of an institutional series spanning 28 years","volume":"31","author":"Juhlin","year":"2020","journal-title":"Endocr Pathol"},{"issue":"11","key":"2023091509045933600_bnad009-B63","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1056\/NEJM198803173181102","article-title":"Monoclonality and abnormal parathyroid hormone genes in parathyroid adenomas","volume":"318","author":"Arnold","year":"1988","journal-title":"N Engl J Med"},{"issue":"12","key":"2023091509045933600_bnad009-B64","first-page":"4789","article-title":"Parathyroid expression of calcium-sensing receptor protein and in vivo parathyroid hormone-Ca2+ set-point in patients with primary hyperparathyroidism","volume":"85","author":"Cetani","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"2023091509045933600_bnad009-B65","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1056\/NEJMcp1714213","article-title":"Primary hyperparathyroidism","volume":"379","author":"Insogna","year":"2018","journal-title":"N Engl J Med"},{"issue":"10","key":"2023091509045933600_bnad009-B66","doi-asserted-by":"crossref","first-page":"E1995","DOI":"10.1210\/jc.2012-2303","article-title":"Whole-exome sequencing studies of nonhereditary (sporadic) parathyroid adenomas","volume":"97","author":"Newey","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"May 14","key":"2023091509045933600_bnad009-B67","doi-asserted-by":"crossref","first-page":"631680","DOI":"10.3389\/fendo.2021.631680","article-title":"Integrated whole-exome and transcriptome sequencing of sporadic parathyroid adenoma","volume":"12","author":"Hu","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"9","key":"2023091509045933600_bnad009-B68","doi-asserted-by":"crossref","first-page":"E1774","DOI":"10.1210\/jc.2012-1743","article-title":"Identification of somatic mutations in parathyroid tumors using whole-exome sequencing","volume":"97","author":"Cromer","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"22","key":"2023091509045933600_bnad009-B69","first-page":"8022","article-title":"Parathyroid gland-specific deletion of the mouse Men1 gene results in parathyroid neoplasia and hypercalcemic hyperparathyroidism","volume":"63","author":"Libutti","year":"2003","journal-title":"Cancer Res"},{"issue":"6159","key":"2023091509045933600_bnad009-B70","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/332085a0","article-title":"Multiple endocrine neoplasia type 1 gene maps to chromosome 11 and is lost in insulinoma","volume":"332","author":"Larsson","year":"1988","journal-title":"Nature"},{"issue":"5","key":"2023091509045933600_bnad009-B71","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1073\/pnas.87.5.1968","article-title":"Localization of the MEN1 gene to a small region within chromosome 11q13 by deletion mapping in tumors","volume":"87","author":"Bystrom","year":"1990","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5311","key":"2023091509045933600_bnad009-B72","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1126\/science.276.5311.404","article-title":"Positional cloning of the gene for multiple endocrine neoplasia-type 1","volume":"276","author":"Chandrasekharappa","year":"1997","journal-title":"Science"},{"issue":"7","key":"2023091509045933600_bnad009-B73","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1093\/hmg\/6.7.1177","article-title":"Identification of the multiple endocrine neoplasia type 1 (MEN1) gene. The European Consortium on MEN1","volume":"6","author":"Lemmens","year":"1997","journal-title":"Hum Mol Genet"},{"issue":"2","key":"2023091509045933600_bnad009-B74","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1530\/EJE-12-0327","article-title":"MEN1 intragenic deletions may represent the most prevalent somatic event in sporadic primary hyperparathyroidism","volume":"168","author":"Alvelos","year":"2013","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"2023091509045933600_bnad009-B75","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1210\/endrev\/bnaa031","article-title":"Multiple endocrine neoplasia type 1: latest insights","volume":"42","author":"Brandi","year":"2020","journal-title":"Endocr Rev"},{"issue":"1","key":"2023091509045933600_bnad009-B76","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1038\/s41467-020-14614-4","article-title":"MEN1 deficiency leads to neuroendocrine differentiation of lung cancer and disrupts the DNA damage response","volume":"11","author":"Qiu","year":"2020","journal-title":"Nat Commun"},{"issue":"36","key":"2023091509045933600_bnad009-B77","doi-asserted-by":"crossref","first-page":"31742","DOI":"10.1074\/jbc.M111.258186","article-title":"Crystal structure of menin reveals binding site for mixed lineage leukemia (MLL) protein","volume":"286","author":"Murai","year":"2011","journal-title":"J Biol Chem"},{"issue":"7386","key":"2023091509045933600_bnad009-B78","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/nature10806","article-title":"The same pocket in menin binds both MLL and JUND but has opposite effects on transcription","volume":"482","author":"Huang","year":"2012","journal-title":"Nature"},{"issue":"2","key":"2023091509045933600_bnad009-B79","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.cell.2005.09.025","article-title":"The menin tumor suppressor protein is an essential oncogenic cofactor for MLL-associated leukemogenesis","volume":"123","author":"Yokoyama","year":"2005","journal-title":"Cell"},{"issue":"6","key":"2023091509045933600_bnad009-B80","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1172\/JCI114114","article-title":"Molecular cloning and chromosomal mapping of DNA rearranged with the parathyroid hormone gene in a parathyroid adenoma","volume":"83","author":"Arnold","year":"1989","journal-title":"J Clin Invest"},{"issue":"6318","key":"2023091509045933600_bnad009-B81","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/350512a0","article-title":"A novel cyclin encoded by a bcl1-linked candidate oncogene","volume":"350","author":"Motokura","year":"1991","journal-title":"Nature"},{"issue":"11","key":"2023091509045933600_bnad009-B82","doi-asserted-by":"crossref","first-page":"E250","DOI":"10.1038\/ncb1101-e250","article-title":"A family outing: small GTPases cyclin\u2019 through G1","volume":"3","author":"Coleman","year":"2001","journal-title":"Nat Cell Biol"},{"issue":"4","key":"2023091509045933600_bnad009-B83","first-page":"412","article-title":"Expression of cyclin D1 in parathyroid carcinomas, adenomas, and hyperplasias: a paraffin immunohistochemical study","volume":"12","author":"Vasef","year":"1999","journal-title":"Mod Pathol"},{"issue":"3","key":"2023091509045933600_bnad009-B84","first-page":"463","article-title":"Immunohistochemistry of cyclin D1 and beta-catenin, and mutational analysis of exon 3 of beta-catenin gene in parathyroid adenomas","volume":"20","author":"Ikeda","year":"2002","journal-title":"Int J Oncol"},{"issue":"5","key":"2023091509045933600_bnad009-B85","first-page":"1736","article-title":"Cyclin D1\/PRAD1 expression in parathyroid adenomas: an immunohistochemical study","volume":"81","author":"Hsi","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2023091509045933600_bnad009-B86","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1016\/S0002-9440(10)64086-2","article-title":"Deletion of 11q23 and cyclin D1 overexpression are frequent aberrations in parathyroid adenomas","volume":"158","author":"Hemmer","year":"2001","journal-title":"Am J Pathol"},{"issue":"4","key":"2023091509045933600_bnad009-B87","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1046\/j.1523-1755.1999.00396.x","article-title":"Expression of PRAD1\/cyclin D1, retinoblastoma gene products, and Ki67 in parathyroid hyperplasia caused by chronic renal failure versus primary adenoma","volume":"55","author":"Tominaga","year":"1999","journal-title":"Kidney Int"},{"issue":"8","key":"2023091509045933600_bnad009-B88","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1002\/gcc.20565","article-title":"Chromosome 11 genomic changes in parathyroid adenoma and hyperplasia: array CGH, FISH, and tissue microarrays","volume":"47","author":"Yi","year":"2008","journal-title":"Genes Chromosomes Cancer"},{"issue":"10","key":"2023091509045933600_bnad009-B89","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1210\/me.2005-0116","article-title":"Abnormal parathyroid cell proliferation precedes biochemical abnormalities in a mouse model of primary hyperparathyroidism","volume":"19","author":"Mallya","year":"2005","journal-title":"Mol Endocrinol"},{"issue":"9","key":"2023091509045933600_bnad009-B90","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1172\/JCI10523","article-title":"Primary hyperparathyroidism caused by parathyroid-targeted overexpression of cyclin D1 in transgenic mice","volume":"107","author":"Imanishi","year":"2001","journal-title":"J Clin Invest"},{"issue":"1","key":"2023091509045933600_bnad009-B91","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0092-8674(94)90572-X","article-title":"Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals","volume":"78","author":"Polyak","year":"1994","journal-title":"Cell"},{"issue":"5257","key":"2023091509045933600_bnad009-B92","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1126\/science.271.5257.1861","article-title":"Translational control of p27Kip1 accumulation during the cell cycle","volume":"271","author":"Hengst","year":"1996","journal-title":"Science"},{"issue":"5","key":"2023091509045933600_bnad009-B93","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1182\/blood.V86.5.1924.bloodjournal8651924","article-title":"Alterations of the p27KIP1 gene in non-Hodgkin's lymphomas and adult T-cell leukemia\/lymphoma","volume":"86","author":"Morosetti","year":"1995","journal-title":"Blood"},{"issue":"10","key":"2023091509045933600_bnad009-B94","first-page":"2400","article-title":"p27\/Kip1 mutation found in breast cancer","volume":"56","author":"Spirin","year":"1996","journal-title":"Cancer Res"},{"issue":"2","key":"2023091509045933600_bnad009-B95","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.leukres.2004.06.007","article-title":"A novel p27 gene mutation in a case of unclassified myeloproliferative disorder","volume":"29","author":"Pappa","year":"2005","journal-title":"Leuk Res"},{"issue":"8","key":"2023091509045933600_bnad009-B96","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1182\/blood-2015-04-643361","article-title":"Recurrent CDKN1B (p27) mutations in hairy cell leukemia","volume":"126","author":"Dietrich","year":"2015","journal-title":"Blood"},{"issue":"12","key":"2023091509045933600_bnad009-B97","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1038\/ng.2821","article-title":"Somatic mutation of CDKN1B in small intestine neuroendocrine tumors","volume":"45","author":"Francis","year":"2013","journal-title":"Nat Genet"},{"issue":"Suppl 3","key":"2023091509045933600_bnad009-B98","doi-asserted-by":"crossref","first-page":"S1428","DOI":"10.1245\/s10434-014-4351-9","article-title":"Somatic mutations and genetic heterogeneity at the CDKN1B locus in small intestinal neuroendocrine tumors","volume":"22","author":"Crona","year":"2015","journal-title":"Ann Surg Oncol"},{"issue":"9","key":"2023091509045933600_bnad009-B99","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1359\/jbmr.1997.12.9.1330","article-title":"Parathyroid tumor suppressor on 1p: analysis of the p18 cyclin-dependent kinase inhibitor gene as a candidate","volume":"12","author":"Tahara","year":"1997","journal-title":"J Bone Miner Res"},{"issue":"4","key":"2023091509045933600_bnad009-B100","doi-asserted-by":"crossref","first-page":"E701","DOI":"10.1210\/jc.2010-1338","article-title":"Somatic mutation and germline sequence abnormalities in CDKN1B, encoding p27Kip1, in sporadic parathyroid adenomas","volume":"96","author":"Costa-Guda","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2023091509045933600_bnad009-B101","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s12672-013-0147-9","article-title":"Germline and somatic mutations in cyclin-dependent kinase inhibitor genes CDKN1A, CDKN2B, and CDKN2C in sporadic parathyroid adenomas","volume":"4","author":"Costa-Guda","year":"2013","journal-title":"Horm Cancer"},{"issue":"6","key":"2023091509045933600_bnad009-B102","doi-asserted-by":"crossref","first-page":"L27","DOI":"10.1530\/ERC-13-0445","article-title":"Mutations in CDKN2C (p18) and CDKN2D (p19) may cause sporadic parathyroid adenoma","volume":"20","author":"Gluick","year":"2013","journal-title":"Endocr Relat Cancer"},{"issue":"4","key":"2023091509045933600_bnad009-B103","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/S1097-2765(04)00081-4","article-title":"Menin associates with a trithorax family histone methyltransferase complex and with the hoxc8 locus","volume":"13","author":"Hughes","year":"2004","journal-title":"Mol Cell"},{"issue":"41","key":"2023091509045933600_bnad009-B104","doi-asserted-by":"crossref","first-page":"14659","DOI":"10.1073\/pnas.0503484102","article-title":"Menin regulates pancreatic islet growth by promoting histone methylation and expression of genes encoding p27Kip1 and p18INK4c","volume":"102","author":"Karnik","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"2023091509045933600_bnad009-B105","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1007\/s12020-016-0941-6","article-title":"Loss of p27 expression is associated with MEN1 gene mutations in sporadic parathyroid adenomas","volume":"55","author":"Borsari","year":"2017","journal-title":"Endocrine"},{"issue":"3","key":"2023091509045933600_bnad009-B106","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/j.1365-2265.2004.01995.x","article-title":"Reduced p18INK4c, p21CIP1\/WAF1 and p27KIP1 mRNA levels in tumours of primary and secondary hyperparathyroidism","volume":"60","author":"Buchwald","year":"2004","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"2023091509045933600_bnad009-B107","doi-asserted-by":"crossref","first-page":"3123","DOI":"10.1038\/s41598-017-03143-8","article-title":"Promoter hypermethylation inactivates CDKN2A, CDKN2B and RASSF1A genes in sporadic parathyroid adenomas","volume":"7","author":"Arya","year":"2017","journal-title":"Sci Rep"},{"issue":"9","key":"2023091509045933600_bnad009-B108","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1002\/gcc.20895","article-title":"The DNA methylome of benign and malignant parathyroid tumors","volume":"50","author":"Starker","year":"2011","journal-title":"Genes Chromosomes Cancer"},{"issue":"3","key":"2023091509045933600_bnad009-B109","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1007\/s12020-012-9690-3","article-title":"Evidence of a stabilizing mutation of \u03b2-catenin encoded by CTNNB1 exon 3 in a large series of sporadic parathyroid adenomas","volume":"42","author":"Starker","year":"2012","journal-title":"Endocrine"},{"issue":"1","key":"2023091509045933600_bnad009-B110","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1007\/s12020-011-9558-y","article-title":"A rare S33C mutation of CTNNB1 encoding \u03b2-catenin in a parathyroid adenoma found in an Italian primary hyperparathyroid cohort","volume":"41","author":"Guarnieri","year":"2012","journal-title":"Endocrine"},{"issue":"1","key":"2023091509045933600_bnad009-B111","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1210\/jc.2006-1197","article-title":"Accumulation of nonphosphorylated beta-catenin and c-myc in primary and uremic secondary hyperparathyroid tumors","volume":"92","author":"Bjorklund","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"issue":"June 9","key":"2023091509045933600_bnad009-B112","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/1476-4598-7-53","article-title":"Stabilizing mutation of CTNNB1\/beta-catenin and protein accumulation analyzed in a large series of parathyroid tumors of Swedish patients","volume":"7","author":"Bjorklund","year":"2008","journal-title":"Mol Cancer"},{"issue":"1","key":"2023091509045933600_bnad009-B113","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1677\/ERC-09-0147","article-title":"Beta-catenin activation is not involved in sporadic parathyroid carcinomas and adenomas","volume":"17","author":"Cetani","year":"2010","journal-title":"Endocr Relat Cancer"},{"issue":"3","key":"2023091509045933600_bnad009-B114","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1385\/EP:11:3:243","article-title":"Nuclear accumulation of B-catenin in human endocrine tumors: association with Ki-67 (MIB-1) proliferative activity","volume":"11","author":"Semba","year":"2000","journal-title":"Endocr Pathol"},{"issue":"11","key":"2023091509045933600_bnad009-B115","doi-asserted-by":"crossref","first-page":"e328","DOI":"10.1371\/journal.pmed.0040328","article-title":"An LRP5 receptor with internal deletion in hyperparathyroid tumors with implications for deregulated WNT\/beta-catenin signaling","volume":"4","author":"Bjorklund","year":"2007","journal-title":"PLoS Med"},{"issue":"3","key":"2023091509045933600_bnad009-B116","doi-asserted-by":"crossref","first-page":"e9472","DOI":"10.1371\/journal.pone.0009472","article-title":"Frequent promoter hypermethylation of the APC and RASSF1A tumour suppressors in parathyroid tumours","volume":"5","author":"Juhlin","year":"2010","journal-title":"PLoS One"},{"issue":"6","key":"2023091509045933600_bnad009-B117","doi-asserted-by":"crossref","first-page":"646","DOI":"10.4161\/epi.24823","article-title":"Global and gene-specific promoter methylation analysis in primary hyperparathyroidism","volume":"8","author":"Sulaiman","year":"2013","journal-title":"Epigenetics"},{"issue":"1","key":"2023091509045933600_bnad009-B118","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1677\/erc.1.01261","article-title":"The association between primary hyperparathyroidism and malignancy: nationwide cohort analysis on cancer incidence after parathyroidectomy","volume":"14","author":"Nilsson","year":"2007","journal-title":"Endocr Relat Cancer"},{"issue":"8","key":"2023091509045933600_bnad009-B119","doi-asserted-by":"crossref","first-page":"bvac096","DOI":"10.1210\/jendso\/bvac096","article-title":"Case of recurrent primary hyperparathyroidism, congenital granular cell tumor, and aggressive colorectal cancer","volume":"6","author":"Afreen","year":"2022","journal-title":"J Endocr Soc"},{"issue":"3","key":"2023091509045933600_bnad009-B120","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s10689-012-9520-z","article-title":"Molecular characterization of parathyroid tumors from two patients with hereditary colorectal cancer syndromes","volume":"11","author":"Andreasson","year":"2012","journal-title":"Fam Cancer"},{"issue":"2","key":"2023091509045933600_bnad009-B121","first-page":"481","article-title":"Loss of expression for the Wnt pathway components adenomatous polyposis coli and glycogen synthase kinase 3-beta in parathyroid carcinomas","volume":"34","author":"Juhlin","year":"2009","journal-title":"Int J Oncol"},{"issue":"3","key":"2023091509045933600_bnad009-B122","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1007\/s12022-010-9121-z","article-title":"Parafibromin and APC as screening markers for malignant potential in atypical parathyroid adenomas","volume":"21","author":"Juhlin","year":"2010","journal-title":"Endocr Pathol"},{"issue":"15","key":"2023091509045933600_bnad009-B123","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1186\/1476-4598-9-294","article-title":"Aberrant WNT\/beta-catenin signaling in parathyroid carcinoma","volume":"9","author":"Svedlund","year":"2010","journal-title":"Mol Cancer"},{"issue":"6","key":"2023091509045933600_bnad009-B124","doi-asserted-by":"crossref","first-page":"e92061","DOI":"10.1172\/jci.insight.92061","article-title":"Genomic profiling reveals mutational landscape in parathyroid carcinomas","volume":"2","author":"Pandya","year":"2017","journal-title":"JCI Insight"},{"issue":"1","key":"2023091509045933600_bnad009-B125","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s13045-020-00937-8","article-title":"EZH2: a novel target for cancer treatment","volume":"13","author":"Duan","year":"2020","journal-title":"J Hematol Oncol"},{"issue":"3","key":"2023091509045933600_bnad009-B126","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.gendis.2019.05.001","article-title":"Mutations in EZH2 are associated with poor prognosis for patients with myeloid neoplasms","volume":"6","author":"Zhang","year":"2019","journal-title":"Genes Dis"},{"issue":"8","key":"2023091509045933600_bnad009-B127","doi-asserted-by":"crossref","first-page":"3061","DOI":"10.1210\/en.2018-00246","article-title":"Whole-exome sequencing identifies novel recurrent somatic mutations in sporadic parathyroid adenomas","volume":"159","author":"Wei","year":"2018","journal-title":"Endocrinology"},{"issue":"3","key":"2023091509045933600_bnad009-B128","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1007\/s12020-016-1142-z","article-title":"EZH2 copy number and mutational analyses in sporadic parathyroid adenomas","volume":"55","author":"Romano","year":"2017","journal-title":"Endocrine"},{"issue":"8","key":"2023091509045933600_bnad009-B129","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1182\/blood-2010-11-321208","article-title":"Somatic mutations at EZH2 Y641 act dominantly through a mechanism of selectively altered PRC2 catalytic activity, to increase H3K27 trimethylation","volume":"117","author":"Yap","year":"2011","journal-title":"Blood"},{"issue":"6","key":"2023091509045933600_bnad009-B130","first-page":"726","article-title":"Menin represses tumorigenesis via repressing cell proliferation","volume":"1","author":"Wu","year":"2011","journal-title":"Am J Cancer Res"},{"issue":"11","key":"2023091509045933600_bnad009-B131","doi-asserted-by":"crossref","first-page":"4028","DOI":"10.1158\/0008-5472.CAN-10-3342","article-title":"EZH2-mediated concordant repression of Wnt antagonists promotes beta-catenin-dependent hepatocarcinogenesis","volume":"71","author":"Cheng","year":"2011","journal-title":"Cancer Res"},{"issue":"2","key":"2023091509045933600_bnad009-B132","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.molcel.2013.08.028","article-title":"PAF and EZH2 induce Wnt\/beta-catenin signaling hyperactivation","volume":"52","author":"Jung","year":"2013","journal-title":"Mol Cell"},{"issue":"November","key":"2023091509045933600_bnad009-B133","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.humpath.2018.04.018","article-title":"Clinical utility of EZH1 mutations in the diagnosis of follicular-patterned thyroid tumors","volume":"81","author":"Jung","year":"2018","journal-title":"Hum Pathol"},{"issue":"8","key":"2023091509045933600_bnad009-B134","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1111\/cas.13655","article-title":"Oncogenic roles of enhancer of zeste homolog 1\/2 in hematological malignancies","volume":"109","author":"Nakagawa","year":"2018","journal-title":"Cancer Sci"},{"issue":"2","key":"2023091509045933600_bnad009-B135","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.cell.2007.03.014","article-title":"Zfx controls the self-renewal of embryonic and hematopoietic stem cells","volume":"129","author":"Galan-Caridad","year":"2007","journal-title":"Cell"},{"issue":"8","key":"2023091509045933600_bnad009-B136","doi-asserted-by":"crossref","first-page":"e42302","DOI":"10.1371\/journal.pone.0042302","article-title":"ZFX controls the self-renewal of human embryonic stem cells","volume":"7","author":"Harel","year":"2012","journal-title":"PLoS One"},{"issue":"11","key":"2023091509045933600_bnad009-B137","doi-asserted-by":"crossref","first-page":"5986","DOI":"10.1093\/nar\/gkaa384","article-title":"Characterization of the ZFX family of transcription factors that bind downstream of the start site of CpG island promoters","volume":"48","author":"Ni","year":"2020","journal-title":"Nucleic Acids Res"},{"issue":"5","key":"2023091509045933600_bnad009-B138","doi-asserted-by":"crossref","first-page":"360","DOI":"10.18632\/oncoscience.38","article-title":"Recurrent ZFX mutations in human sporadic parathyroid adenomas","volume":"1","author":"Soong","year":"2014","journal-title":"Oncoscience"},{"issue":"22","key":"2023091509045933600_bnad009-B139","doi-asserted-by":"crossref","first-page":"3465","DOI":"10.4161\/15384101.2014.980693","article-title":"New role for ZFX in oncogenesis","volume":"13","author":"Arnold","year":"2014","journal-title":"Cell Cycle"},{"issue":"D1","key":"2023091509045933600_bnad009-B140","doi-asserted-by":"crossref","first-page":"D777","DOI":"10.1093\/nar\/gkw1121","article-title":"COSMIC: somatic cancer genetics at high-resolution","volume":"45","author":"Forbes","year":"2017","journal-title":"Nucleic Acids Res"},{"issue":"11","key":"2023091509045933600_bnad009-B141","first-page":"13886","article-title":"Zinc finger protein x-linked (ZFX) contributes to patient prognosis, cell proliferation and apoptosis in human laryngeal squamous cell carcinoma","volume":"8","author":"Yang","year":"2015","journal-title":"Int J Clin Exp Pathol"},{"issue":"4","key":"2023091509045933600_bnad009-B142","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1210\/js.2017-00031","article-title":"Mutational analysis of ZFY in sporadic parathyroid adenomas","volume":"1","author":"Romano","year":"2017","journal-title":"J Endocr Soc"},{"issue":"2","key":"2023091509045933600_bnad009-B143","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1530\/JOE-10-0247","article-title":"Mutational analysis of GCMB, a parathyroid-specific transcription factor, in parathyroid adenoma of primary hyperparathyroidism","volume":"210","author":"Mannstadt","year":"2011","journal-title":"J Endocrinol"},{"issue":"5","key":"2023091509045933600_bnad009-B144","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/j.ajhg.2016.08.018","article-title":"GCM2-activating mutations in familial isolated hyperparathyroidism","volume":"99","author":"Guan","year":"2016","journal-title":"Am J Hum Genet"},{"issue":"6","key":"2023091509045933600_bnad009-B145","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/0092-8674(95)90281-3","article-title":"Hotta Y. glial cells missing: a binary switch between neuronal and glial determination in Drosophila","volume":"82","author":"Hosoya","year":"1995","journal-title":"Cell"},{"issue":"6","key":"2023091509045933600_bnad009-B146","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/0092-8674(95)90280-5","article-title":"Goodman CS. glial cells missing: a genetic switch that controls glial versus neuronal fate","volume":"82","author":"Jones","year":"1995","journal-title":"Cell"},{"issue":"1-2","key":"2023091509045933600_bnad009-B147","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1159\/000015210","article-title":"GCMB, a second human homolog of the fly glide\/gcm gene","volume":"84","author":"Kammerer","year":"1999","journal-title":"Cytogenet Cell Genet"},{"issue":"25","key":"2023091509045933600_bnad009-B148","doi-asserted-by":"crossref","first-page":"14912","DOI":"10.1073\/pnas.93.25.14912","article-title":"The gcm-motif: a novel DNA-binding motif conserved in Drosophila and mammals","volume":"93","author":"Akiyama","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2-3","key":"2023091509045933600_bnad009-B149","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0014-5793(96)00890-3","article-title":"Gcm1, a mammalian homolog of Drosophila glial cells missing","volume":"393","author":"Altshuller","year":"1996","journal-title":"FEBS Lett"},{"issue":"21","key":"2023091509045933600_bnad009-B150","doi-asserted-by":"crossref","first-page":"12364","DOI":"10.1073\/pnas.95.21.12364","article-title":"Isolation and characterization of mammalian homologs of the Drosophila gene glial cells missing","volume":"95","author":"Kim","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2-3","key":"2023091509045933600_bnad009-B151","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0014-5793(98)01650-0","article-title":"Isolation and expression analysis of a novel human homologue of the Drosophila glial cells missing (gcm) gene","volume":"442","author":"Kanemura","year":"1999","journal-title":"FEBS Lett"},{"issue":"6792","key":"2023091509045933600_bnad009-B152","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/35018111","article-title":"Genetic ablation of parathyroid glands reveals another source of parathyroid hormone","volume":"406","author":"Gunther","year":"2000","journal-title":"Nature"},{"issue":"6","key":"2023091509045933600_bnad009-B153","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/j.surg.2004.06.056","article-title":"GCMB gene, a master regulator of parathyroid gland development, expression, and regulation in hyperparathyroidism","volume":"136","author":"Kebebew","year":"2004","journal-title":"Surgery"},{"issue":"3","key":"2023091509045933600_bnad009-B154","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1530\/EJE-21-0433","article-title":"Novel glial cells missing-2 (GCM2) variants in parathyroid disorders","volume":"186","author":"Canaff","year":"2022","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"2023091509045933600_bnad009-B155","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1530\/EJE-13-0085","article-title":"Simultaneous expression analysis of vitamin D receptor, calcium-sensing receptor, cyclin D1, and PTH in symptomatic primary hyperparathyroidism in Asian Indians","volume":"169","author":"Varshney","year":"2013","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"2023091509045933600_bnad009-B156","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1046\/j.1365-2265.2000.00933.x","article-title":"Calcium-sensing receptor expression and signalling in human parathyroid adenomas and primary hyperplasia","volume":"52","author":"Corbetta","year":"2000","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"2023091509045933600_bnad009-B157","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/ki.1997.41","article-title":"Depressed expression of calcium receptor in parathyroid gland tissue of patients with hyperparathyroidism","volume":"51","author":"Gogusev","year":"1997","journal-title":"Kidney Int"},{"issue":"4","key":"2023091509045933600_bnad009-B158","first-page":"1598","article-title":"Reduced immunostaining for the extracellular Ca2+-sensing receptor in primary and uremic secondary hyperparathyroidism","volume":"81","author":"Kifor","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"2023091509045933600_bnad009-B159","first-page":"3481","article-title":"Tumor-specific decreased expression of calcium sensing receptor messenger ribonucleic acid in sporadic primary hyperparathyroidism","volume":"82","author":"Farnebo","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2023091509045933600_bnad009-B160","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1067\/msy.1998.91828","article-title":"Decreased expression of calcium-sensing receptor messenger ribonucleic acids in parathyroid adenomas","volume":"124","author":"Farnebo","year":"1998","journal-title":"Surgery"},{"issue":"12","key":"2023091509045933600_bnad009-B161","doi-asserted-by":"crossref","first-page":"5019","DOI":"10.1210\/jc.2006-1543","article-title":"Mutational analysis of the vitamin D receptor does not support its candidacy as a tumor suppressor gene in parathyroid adenomas","volume":"91","author":"Samander","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2023091509045933600_bnad009-B162","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1359\/jbmr.1999.14.6.878","article-title":"No evidence for mutations in the calcium-sensing receptor gene in sporadic parathyroid adenomas","volume":"14","author":"Cetani","year":"1999","journal-title":"J Bone Miner Res"},{"issue":"9","key":"2023091509045933600_bnad009-B163","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.1210\/clinem\/dgaa419","article-title":"Reduced calcium sensing receptor (CaSR) expression is epigenetically deregulated in parathyroid adenomas","volume":"105","author":"Singh","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2023091509045933600_bnad009-B164","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1210\/me.2010-0277","article-title":"Regulator of G protein signaling 5 is highly expressed in parathyroid tumors and inhibits signaling by the calcium-sensing receptor","volume":"25","author":"Koh","year":"2011","journal-title":"Mol Endocrinol"},{"issue":"3","key":"2023091509045933600_bnad009-B165","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1002\/jbmr.3023","article-title":"Orphan adhesion GPCR GPR64\/ADGRG2 is overexpressed in parathyroid tumors and attenuates calcium-sensing receptor-mediated signaling","volume":"32","author":"Balenga","year":"2017","journal-title":"J Bone Miner Res"},{"issue":"2","key":"2023091509045933600_bnad009-B166","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1530\/JME-16-0184","article-title":"Filamin A is reduced and contributes to the CASR sensitivity in human parathyroid tumors","volume":"58","author":"Mingione","year":"2017","journal-title":"J Mol Endocrinol"},{"issue":"4","key":"2023091509045933600_bnad009-B167","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.3390\/ijms22042016","article-title":"Yes-associated protein 1 is a novel calcium sensing receptor target in human parathyroid tumors","volume":"22","author":"Tavanti","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"7","key":"2023091509045933600_bnad009-B168","doi-asserted-by":"crossref","first-page":"2800","DOI":"10.1210\/jc.2012-4029","article-title":"Aryl hydrocarbon receptor interacting protein (AIP) mutations occur rarely in sporadic parathyroid adenomas","volume":"98","author":"Pardi","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"2023091509045933600_bnad009-B169","first-page":"2711","article-title":"Role of the RET proto-oncogene in sporadic hyperparathyroidism and in hyperparathyroidism of multiple endocrine neoplasia type 2","volume":"81","author":"Pausova","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2023091509045933600_bnad009-B170","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/S0039-6060(98)70093-5","article-title":"Multiple endocrine neoplasia type 2-associated RET proto-oncogene mutations do not contribute to the pathogenesis of sporadic parathyroid tumors","volume":"124","author":"Willeke","year":"1998","journal-title":"Surgery"},{"issue":"9","key":"2023091509045933600_bnad009-B171","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1136\/jmg.40.9.657","article-title":"HRPT2 mutations are associated with malignancy in sporadic parathyroid tumours","volume":"40","author":"Howell","year":"2003","journal-title":"J Med Genet"},{"issue":"9","key":"2023091509045933600_bnad009-B172","doi-asserted-by":"crossref","first-page":"5015","DOI":"10.1210\/jc.2005-0717","article-title":"HRPT2 mutational analysis of typical sporadic parathyroid adenomas","volume":"90","author":"Krebs","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2023091509045933600_bnad009-B173","doi-asserted-by":"crossref","first-page":"e10360","DOI":"10.1002\/jbm4.10360","article-title":"PIK3CA mutational analysis of parathyroid adenomas","volume":"4","author":"Riccardi","year":"2020","journal-title":"JBMR Plus"},{"issue":"5","key":"2023091509045933600_bnad009-B174","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s00595-003-2729-6","article-title":"Telomerase activation and expression of its catalytic subunits in benign and malignant tumors of the parathyroid","volume":"34","author":"Onoda","year":"2004","journal-title":"Surg Today"},{"issue":"6","key":"2023091509045933600_bnad009-B175","first-page":"733","article-title":"Diagnosis of parathyroid carcinoma using immunohistochemical staining against hTERT","volume":"24","author":"Osawa","year":"2009","journal-title":"Int J Mol Med"},{"issue":"3","key":"2023091509045933600_bnad009-B176","doi-asserted-by":"crossref","first-page":"L9","DOI":"10.1530\/ERC-15-0121","article-title":"TERT promoter mutations are rare in parathyroid tumors","volume":"22","author":"Haglund","year":"2015","journal-title":"Endocr Relat Cancer"},{"issue":"8","key":"2023091509045933600_bnad009-B177","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1593\/neo.09470","article-title":"Distinct HIC1-SIRT1-p53 loop deregulation in lung squamous carcinoma and adenocarcinoma patients","volume":"11","author":"Tseng","year":"2009","journal-title":"Neoplasia"},{"issue":"3","key":"2023091509045933600_bnad009-B178","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1093\/hmg\/9.3.413","article-title":"Mice deficient in the candidate tumor suppressor gene Hic1 exhibit developmental defects of structures affected in the Miller-Dieker syndrome","volume":"9","author":"Carter","year":"2000","journal-title":"Hum Mol Genet"},{"issue":"2","key":"2023091509045933600_bnad009-B179","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/ng1077","article-title":"Heterozygous disruption of Hic1 predisposes mice to a gender-dependent spectrum of malignant tumors","volume":"33","author":"Chen","year":"2003","journal-title":"Nat Genet"},{"issue":"7","key":"2023091509045933600_bnad009-B180","doi-asserted-by":"crossref","first-page":"E1307","DOI":"10.1210\/jc.2011-3136","article-title":"Hypermethylated in cancer 1 (HIC1), a tumor suppressor gene epigenetically deregulated in hyperparathyroid tumors by histone H3 lysine modification","volume":"97","author":"Svedlund","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"2023091509045933600_bnad009-B181","doi-asserted-by":"crossref","first-page":"a026526","DOI":"10.1101\/cshperspect.a026526","article-title":"The role of additional sex combs-like proteins in cancer","volume":"6","author":"Micol","year":"2016","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"1","key":"2023091509045933600_bnad009-B182","doi-asserted-by":"crossref","first-page":"4828","DOI":"10.1080\/21655979.2021.1955559","article-title":"Prognostic and immunological role of Ras-related protein Rap1b in pan-cancer","volume":"12","author":"Cui","year":"2021","journal-title":"Bioengineered"},{"issue":"6","key":"2023091509045933600_bnad009-B183","doi-asserted-by":"crossref","first-page":"637","DOI":"10.3390\/biomedicines9060637","article-title":"The core stem genes SOX2, POU5F1\/OCT4, and NANOG are expressed in human parathyroid tumors and modulated by MEN1, YAP1, and \u03b2-catenin pathways activation","volume":"9","author":"Verdelli","year":"2021","journal-title":"Biomedicines"},{"issue":"1","key":"2023091509045933600_bnad009-B184","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1677\/ERC-07-0191","article-title":"Parathyroid tumor development involves deregulation of homeobox genes","volume":"15","author":"Shen","year":"2008","journal-title":"Endocr Relat Cancer"},{"issue":"12","key":"2023091509045933600_bnad009-B185","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1038\/labinvest.2017.88","article-title":"Expression, function, and regulation of the embryonic transcription factor TBX1 in parathyroid tumors","volume":"97","author":"Verdelli","year":"2017","journal-title":"Lab Invest"},{"issue":"2","key":"2023091509045933600_bnad009-B186","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1530\/JME-11-0189","article-title":"The microRNA cluster C19MC is deregulated in parathyroid tumours","volume":"49","author":"Vaira","year":"2012","journal-title":"J Mol Endocrinol"},{"key":"2023091509045933600_bnad009-B187","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.mce.2017.04.007","article-title":"Epigenetic processes in sporadic parathyroid neoplasms","volume":"469","author":"Silva-Figueroa","year":"2018","journal-title":"Mol Cell Endocrinol"},{"issue":"2","key":"2023091509045933600_bnad009-B188","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1007\/s12020-015-0555-4","article-title":"Epigenetic alterations in human parathyroid tumors","volume":"49","author":"Verdelli","year":"2015","journal-title":"Endocrine"},{"issue":"7","key":"2023091509045933600_bnad009-B189","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1530\/ERC-17-0204","article-title":"The aberrantly expressed miR-372 partly impairs sensitivity to apoptosis in parathyroid tumor cells","volume":"25","author":"Verdelli","year":"2018","journal-title":"Endocr Relat Cancer"},{"key":"2023091509045933600_bnad009-B190","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.mce.2016.10.035","article-title":"MicroRNAs in parathyroid physiopathology","volume":"456","author":"Vaira","year":"2017","journal-title":"Mol Cell Endocrinol"},{"key":"2023091509045933600_bnad009-B191","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.mce.2017.05.010","article-title":"Alterations of DNA methylation in parathyroid tumors","volume":"469","author":"Guarnieri","year":"2018","journal-title":"Mol Cell Endocrinol"},{"issue":"1","key":"2023091509045933600_bnad009-B192","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1007\/BF02819737","article-title":"Parastruma maligna aberrata","volume":"100","author":"Quervain","year":"1909","journal-title":"Deutsche Zeitschrift fur Chirurgie"},{"issue":"9","key":"2023091509045933600_bnad009-B193","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1002\/cncr.22599","article-title":"Trends in the incidence and treatment of parathyroid cancer in the United States","volume":"109","author":"Lee","year":"2007","journal-title":"Cancer"},{"issue":"8","key":"2023091509045933600_bnad009-B194","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1002\/hed.20049","article-title":"Parathyroid carcinoma: a 22-year experience","volume":"26","author":"Busaidy","year":"2004","journal-title":"Head Neck"},{"issue":"4","key":"2023091509045933600_bnad009-B195","doi-asserted-by":"crossref","first-page":"331","DOI":"10.3949\/ccjm.60.4.331","article-title":"Parathyroid carcinoma: 50-year experience at the Cleveland Clinic Foundation","volume":"60","author":"Hakaim","year":"1993","journal-title":"Cleve Clin J Med"},{"issue":"6","key":"2023091509045933600_bnad009-B196","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/j.surg.2007.09.014","article-title":"Functional parathyroid carcinoma: long-term treatment outcome and risk factor analysis","volume":"142","author":"Iihara","year":"2007","journal-title":"Surgery"},{"issue":"12","key":"2023091509045933600_bnad009-B197","doi-asserted-by":"crossref","first-page":"3679","DOI":"10.1210\/jc.2011-1571","article-title":"Parathyroid carcinoma: a 43-year outcome and survival analysis","volume":"96","author":"Harari","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"2023091509045933600_bnad009-B198","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1001\/archsurg.136.8.878","article-title":"Localization and reoperation results for persistent and recurrent parathyroid carcinoma","volume":"136","author":"Kebebew","year":"2001","journal-title":"Arch Surg"},{"issue":"8","key":"2023091509045933600_bnad009-B199","doi-asserted-by":"crossref","first-page":"T53","DOI":"10.1530\/ERC-20-0018","article-title":"Hereditary endocrine tumours: current state-of-the-art and research opportunities: new and future perspectives for parathyroid carcinoma","volume":"27","author":"Perrier","year":"2020","journal-title":"Endocr Relat Cancer"},{"issue":"3","key":"2023091509045933600_bnad009-B200","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1245\/ASO.2005.03.036","article-title":"Is parathyroid carcinoma indeed a lethal disease?","volume":"12","author":"Kleinpeter","year":"2005","journal-title":"Ann Surg Oncol"},{"key":"2023091509045933600_bnad009-B201","first-page":"147","volume-title":"WHO Classification of Tumours of Endocrine Organs","author":"DeLellis","year":"2017","edition":"4th ed."},{"issue":"4","key":"2023091509045933600_bnad009-B202","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1007\/BF02067369","article-title":"Prognostic factors in parathyroid cancer: a review of 95 cases","volume":"16","author":"Sandelin","year":"1992","journal-title":"World J Surg"},{"issue":"Apr","key":"2023091509045933600_bnad009-B203","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.humpath.2020.07.008","article-title":"Pathology data set for reporting parathyroid carcinoma and atypical parathyroid neoplasm: recommendations from the International Collaboration on Cancer Reporting","volume":"110","author":"Williams","year":"2021","journal-title":"Hum Pathol"},{"issue":"6","key":"2023091509045933600_bnad009-B204","first-page":"649","article-title":"Parathyroid carcinoma versus parathyroid adenoma in patients with profound hypercalcemia","volume":"101","author":"Levin","year":"1987","journal-title":"Surgery"},{"issue":"11","key":"2023091509045933600_bnad009-B205","doi-asserted-by":"crossref","first-page":"e4565","DOI":"10.1210\/clinem\/dgab452","article-title":"Do patients with atypical parathyroid adenoma need a close follow-up?","volume":"106","author":"Saponaro","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"2023091509045933600_bnad009-B206","doi-asserted-by":"crossref","first-page":"2889","DOI":"10.1245\/s10434-016-5248-6","article-title":"Differentiating atypical parathyroid neoplasm from parathyroid cancer","volume":"23","author":"Christakis","year":"2016","journal-title":"Ann Surg Oncol"},{"issue":"7","key":"2023091509045933600_bnad009-B207","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1080\/0284186X.2017.1306103","article-title":"A nationwide study on parathyroid carcinoma","volume":"56","author":"Ryh\u00e4nen","year":"2017","journal-title":"Acta Oncol"},{"issue":"4","key":"2023091509045933600_bnad009-B208","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/00005792-199207000-00002","article-title":"Parathyroid carcinoma: clinical and pathologic features in 43 patients","volume":"71","author":"Wynne","year":"1992","journal-title":"Medicine (Baltimore)"},{"issue":"5","key":"2023091509045933600_bnad009-B209","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.amjsurg.2010.09.025","article-title":"Incidence and prognosis of parathyroid gland carcinoma: a population-based study in The Netherlands estimating the preoperative diagnosis","volume":"202","author":"Schaapveld","year":"2011","journal-title":"Am J Surg"},{"issue":"1","key":"2023091509045933600_bnad009-B210","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1200\/JOP.19.00540","article-title":"Contemporary evaluation and management of parathyroid carcinoma","volume":"17","author":"Fingeret","year":"2021","journal-title":"JCO Oncol Pract"},{"issue":"9","key":"2023091509045933600_bnad009-B211","doi-asserted-by":"crossref","first-page":"e46325","DOI":"10.1371\/journal.pone.0046325","article-title":"Genome-wide and locus specific alterations in CDC73\/HRPT2-mutated parathyroid tumors","volume":"7","author":"Sulaiman","year":"2012","journal-title":"PLoS One"},{"issue":"6","key":"2023091509045933600_bnad009-B212","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1507\/endocrj.EJ14-0023","article-title":"Gene identification of potential malignant parathyroid tumors phenotype in Chinese population","volume":"61","author":"Zhao","year":"2014","journal-title":"Endocr J"},{"issue":"1","key":"2023091509045933600_bnad009-B213","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1677\/ERC-09-0134","article-title":"Differential expression of microRNAs in human parathyroid carcinomas compared with normal parathyroid tissue","volume":"17","author":"Corbetta","year":"2010","journal-title":"Endocr Relat Cancer"},{"issue":"4","key":"2023091509045933600_bnad009-B214","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1245\/s10434-010-1359-7","article-title":"Identification of differentially expressed microRNA in parathyroid tumors","volume":"18","author":"Rahbari","year":"2011","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"2023091509045933600_bnad009-B215","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1007\/s12020-018-1551-2","article-title":"Verification of candidate microRNA markers for parathyroid carcinoma","volume":"60","author":"Hu","year":"2018","journal-title":"Endocrine"},{"issue":"9","key":"2023091509045933600_bnad009-B216","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1080\/15476286.2019.1622962","article-title":"Circular RNA profile of parathyroid neoplasms: analysis of co-expression networks of circular RNAs and mRNAs","volume":"16","author":"Hu","year":"2019","journal-title":"RNA Biol"},{"issue":"7","key":"2023091509045933600_bnad009-B217","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1007\/s00198-019-04959-y","article-title":"Genome-wide analysis of differentially expressed lncRNA in sporadic parathyroid tumors","volume":"30","author":"Jiang","year":"2019","journal-title":"Osteoporos Int"},{"issue":"2","key":"2023091509045933600_bnad009-B218","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1530\/ERC-18-0480","article-title":"Profiling analysis of long non-coding RNA and mRNA in parathyroid carcinoma","volume":"26","author":"Zhang","year":"2019","journal-title":"Endocr Relat Cancer"},{"issue":"1","key":"2023091509045933600_bnad009-B219","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s12020-020-02535-7","article-title":"Expression profile of serum-related exosomal miRNAs from parathyroid tumor","volume":"72","author":"Wang","year":"2021","journal-title":"Endocrine"},{"issue":"2","key":"2023091509045933600_bnad009-B220","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1245\/s10434-013-3288-8","article-title":"Negative parafibromin staining predicts malignant behavior in atypical parathyroid adenomas","volume":"21","author":"Kruijff","year":"2014","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"2023091509045933600_bnad009-B221","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1530\/EJE-06-0720","article-title":"Should parafibromin staining replace HRTP2 gene analysis as an additional tool for histologic diagnosis of parathyroid carcinoma?","volume":"156","author":"Cetani","year":"2007","journal-title":"Eur J Endocrinol"},{"issue":"8","key":"2023091509045933600_bnad009-B222","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1038\/s41379-019-0252-6","article-title":"Parafibromin immunostainings of parathyroid tumors in clinical routine: a near-decade experience from a tertiary center","volume":"32","author":"Juhlin","year":"2019","journal-title":"Mod Pathol"},{"issue":"2","key":"2023091509045933600_bnad009-B223","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1002\/cncr.24037","article-title":"Defining a molecular phenotype for benign and malignant parathyroid tumors","volume":"115","author":"Fernandez-Ranvier","year":"2009","journal-title":"Cancer"},{"issue":"2","key":"2023091509045933600_bnad009-B224","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1210\/jc.2008-1740","article-title":"Accuracy of combined protein gene product 9.5 and parafibromin markers for immunohistochemical diagnosis of parathyroid carcinoma","volume":"94","author":"Howell","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2023091509045933600_bnad009-B225","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s13402-012-0100-x","article-title":"CDC73 mutations and parafibromin immunohistochemistry in parathyroid tumors: clinical correlations in a single-centre patient cohort","volume":"35","author":"Guarnieri","year":"2012","journal-title":"Cell Oncol (Dordr)"},{"issue":"9","key":"2023091509045933600_bnad009-B226","doi-asserted-by":"crossref","first-page":"e45567","DOI":"10.1371\/journal.pone.0045567","article-title":"Novel HRPT2\/CDC73 gene mutations and loss of expression of parafibromin in Chinese patients with clinically sporadic parathyroid carcinomas","volume":"7","author":"Wang","year":"2012","journal-title":"PLoS One"},{"issue":"3","key":"2023091509045933600_bnad009-B227","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1007\/s12020-016-0997-3","article-title":"Diagnostic performance of parafibromin immunohistochemical staining for sporadic parathyroid carcinoma: a meta-analysis","volume":"54","author":"Hu","year":"2016","journal-title":"Endocrine"},{"issue":"7","key":"2023091509045933600_bnad009-B228","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1007\/s00423-015-1361-4","article-title":"Evaluation of malignant parathyroid tumours in two European cohorts of patients with sporadic primary hyperparathyroidism","volume":"401","author":"Ozolins","year":"2016","journal-title":"Langenbecks Arch Surg"},{"issue":"6","key":"2023091509045933600_bnad009-B229","doi-asserted-by":"crossref","first-page":"421","DOI":"10.5001\/omj.2015.84","article-title":"The role of parafibromin, galectin-3, HBME-1, and Ki-67 in the differential diagnosis of parathyroid tumors","volume":"30","author":"Karaarslan","year":"2015","journal-title":"Oman Med J"},{"issue":"11","key":"2023091509045933600_bnad009-B230","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.1007\/s00268-014-2700-2","article-title":"Parafibromin, galectin-3, PGP9.5, Ki67, and cyclin D1: using an immunohistochemical panel to aid in the diagnosis of parathyroid cancer","volume":"38","author":"Truran","year":"2014","journal-title":"World J Surg"},{"issue":"2","key":"2023091509045933600_bnad009-B231","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s12022-016-9426-7","article-title":"Role of histological criteria and immunohistochemical markers in predicting risk of malignancy in parathyroid neoplasms","volume":"27","author":"Kumari","year":"2016","journal-title":"Endocr Pathol"},{"issue":"2","key":"2023091509045933600_bnad009-B232","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/hed.21716","article-title":"Parafibromin immunohistochemical staining to differentiate parathyroid carcinoma from parathyroid adenoma","volume":"34","author":"Kim","year":"2012","journal-title":"Head Neck"},{"issue":"4","key":"2023091509045933600_bnad009-B233","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1530\/EC-13-0046","article-title":"CDC73 mutational status and loss of parafibromin in the outcome of parathyroid cancer","volume":"2","author":"Cetani","year":"2013","journal-title":"Endocr Connect"},{"issue":"8","key":"2023091509045933600_bnad009-B234","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.humpath.2005.06.020","article-title":"Galectin-3 expression in parathyroid carcinoma: immunohistochemical study of 26 cases","volume":"36","author":"Bergero","year":"2005","journal-title":"Hum Pathol"},{"issue":"1","key":"2023091509045933600_bnad009-B235","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1053\/hupa.2003.55","article-title":"Parathyroid neoplasms: clinical, histopathological, and tissue microarray-based molecular analysis","volume":"34","author":"Stojadinovic","year":"2003","journal-title":"Hum Pathol"},{"issue":"2","key":"2023091509045933600_bnad009-B236","first-page":"421","article-title":"Alterations in the retinoblastoma pathway of cell cycle control in parathyroid tumors","volume":"7","author":"Szijan","year":"2000","journal-title":"Oncol Rep"},{"issue":"1","key":"2023091509045933600_bnad009-B237","doi-asserted-by":"crossref","first-page":"22","DOI":"10.4103\/IJPM.IJPM_85_17","article-title":"Role of calcium-sensing receptor, Galectin-3, Cyclin D1, and Ki-67 immunohistochemistry to favor in the diagnosis of parathyroid carcinoma","volume":"61","author":"Sungu","year":"2018","journal-title":"Indian J Pathol Microbiol"},{"issue":"3","key":"2023091509045933600_bnad009-B238","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s00268-015-3380-2","article-title":"Molecular characteristics of large parathyroid adenomas","volume":"40","author":"Agarwal","year":"2016","journal-title":"World J Surg"},{"issue":"5","key":"2023091509045933600_bnad009-B239","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/modpathol.2010.236","article-title":"Downregulation of CASR expression and global loss of parafibromin staining are strong negative determinants of prognosis in parathyroid carcinoma","volume":"24","author":"Witteveen","year":"2011","journal-title":"Mod Pathol"},{"issue":"11","key":"2023091509045933600_bnad009-B240","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1056\/NEJM199403173301105","article-title":"Loss of the retinoblastoma tumor-suppressor gene in parathyroid carcinoma","volume":"330","author":"Cryns","year":"1994","journal-title":"N Engl J Med"},{"issue":"3","key":"2023091509045933600_bnad009-B241","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s12253-011-9483-7","article-title":"Molecular profiling of parathyroid hyperplasia, adenoma and carcinoma","volume":"18","author":"\u00c1rvai","year":"2012","journal-title":"Pathol Oncol Res"},{"issue":"4","key":"2023091509045933600_bnad009-B242","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1530\/EJE-08-0662","article-title":"Unique expression pattern of the EMT markers Snail, Twist and E-cadherin in benign and malignant parathyroid neoplasia","volume":"160","author":"Fendrich","year":"2009","journal-title":"Eur J Endocrinol"},{"issue":"10","key":"2023091509045933600_bnad009-B243","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1007\/s00268-015-3149-7","article-title":"Immunohistochemical expression of E-Cadherin in atypical parathyroid adenoma","volume":"39","author":"Schneider","year":"2015","journal-title":"World J Surg"},{"issue":"1","key":"2023091509045933600_bnad009-B244","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.eprac.2020.11.004","article-title":"Pd-L1 expression in normal endocrine tissues is not increased despite high incidence of Pd-1 inhibitor-associated endocrinopathies","volume":"27","author":"Pollack","year":"2021","journal-title":"Endocr Pract"},{"issue":"7","key":"2023091509045933600_bnad009-B245","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1530\/EC-19-0163","article-title":"Programmed death ligand 1 (PD-L1) expression in parathyroid tumors","volume":"8","author":"Pan","year":"2019","journal-title":"Endocr Connect"},{"issue":"4","key":"2023091509045933600_bnad009-B246","doi-asserted-by":"crossref","first-page":"383","DOI":"10.4183\/aeb.2016.383","article-title":"Clinical significance of Pd-L1 expression in parathyroid cancer","volume":"12","author":"Du","year":"2016","journal-title":"Acta Endocrinol (Buchar)"},{"issue":"5","key":"2023091509045933600_bnad009-B247","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.surg.2018.06.013","article-title":"Characterizing parathyroid carcinomas and atypical neoplasms based on the expression of programmed death-ligand 1 expression and the presence of tumor-infiltrating lymphocytes and macrophages","volume":"164","author":"Silva-Figueroa","year":"2018","journal-title":"Surgery"},{"issue":"2","key":"2023091509045933600_bnad009-B248","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1530\/ERC-20-0450","article-title":"Gene expression profile in metastatic and non-metastatic parathyroid carcinoma","volume":"28","author":"Condello","year":"2021","journal-title":"Endocr Relat Cancer"},{"issue":"2","key":"2023091509045933600_bnad009-B249","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s12020-013-9903-4","article-title":"Allelic imbalance in sporadic parathyroid carcinoma and evidence for its de novo origins","volume":"44","author":"Costa-Guda","year":"2013","journal-title":"Endocrine"},{"issue":"20","key":"2023091509045933600_bnad009-B250","doi-asserted-by":"crossref","first-page":"7405","DOI":"10.1158\/0008-5472.CAN-04-2063","article-title":"Gene expression of parathyroid tumors: molecular subclassification and identification of the potential malignant phenotype","volume":"64","author":"Haven","year":"2004","journal-title":"Cancer Res"},{"issue":"3","key":"2023091509045933600_bnad009-B251","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1002\/(SICI)1097-0142(19990801)86:3<538::AID-CNCR25>3.0.CO;2-K","article-title":"Two hundred eighty-six cases of parathyroid carcinoma treated in the U.S. between 1985-1995: a National Cancer Data Base Report. The American College of Surgeons Commission on Cancer and the American Cancer Society","volume":"86","author":"Hundahl","year":"1999","journal-title":"Cancer"},{"issue":"11","key":"2023091509045933600_bnad009-B252","doi-asserted-by":"crossref","first-page":"3593","DOI":"10.1245\/s10434-019-07451-3","article-title":"Risk of distant metastasis in parathyroid carcinoma and its effect on survival: a retrospective review from a high-volume center","volume":"26","author":"Asare","year":"2019","journal-title":"Ann Surg Oncol"},{"key":"2023091509045933600_bnad009-B253","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/1750-1172-8-115","article-title":"Highly aggressive pathology of non-functional parathyroid carcinoma","volume":"8","author":"Piciu","year":"2013","journal-title":"Orphanet J Rare Dis"},{"key":"2023091509045933600_bnad009-B254","first-page":"731481","article-title":"Nonfunctional metastatic parathyroid carcinoma in the setting of multiple endocrine neoplasia type 2A syndrome","volume":"2014","author":"Posada-Gonz\u00e1lez","year":"2014","journal-title":"Surg Res Pract"},{"issue":"2","key":"2023091509045933600_bnad009-B255","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1007\/s12105-009-0115-4","article-title":"Non-functional parathyroid carcinoma: a review of the literature and report of a case requiring extensive surgery","volume":"3","author":"Wilkins","year":"2009","journal-title":"Head Neck Pathol"},{"issue":"1","key":"2023091509045933600_bnad009-B256","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1007\/s12020-019-02136-z","article-title":"Long-term remission of disseminated parathyroid cancer following immunotherapy","volume":"67","author":"Sarquis","year":"2020","journal-title":"Endocrine"},{"issue":"9","key":"2023091509045933600_bnad009-B257","doi-asserted-by":"crossref","first-page":"e235293","DOI":"10.1136\/bcr-2020-235293","article-title":"Microsatellite instability driven metastatic parathyroid carcinoma managed with the anti-PD1 immunotherapy, pembrolizumab","volume":"13","author":"Park","year":"2020","journal-title":"BMJ case Rep"},{"key":"2023091509045933600_bnad009-B258","first-page":"16","article-title":"Diagnosis and treatment challenges of parathyroid carcinoma in a 27-year-old woman with multiple lung metastases","volume":"2017","author":"Rozhinskaya","year":"2017","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"issue":"11","key":"2023091509045933600_bnad009-B259","doi-asserted-by":"crossref","first-page":"5583","DOI":"10.1210\/jc.2004-0294","article-title":"Genetic analyses of the HRPT2 gene in primary hyperparathyroidism: germline and somatic mutations in familial and sporadic parathyroid tumors","volume":"89","author":"Cetani","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"issue":"18","key":"2023091509045933600_bnad009-B260","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1056\/NEJMoa031237","article-title":"Somatic and germ-line mutations of the HRPT2 gene in sporadic parathyroid carcinoma","volume":"349","author":"Shattuck","year":"2003","journal-title":"N Engl J Med"},{"issue":"9","key":"2023091509045933600_bnad009-B261","doi-asserted-by":"crossref","first-page":"2446","DOI":"10.1002\/ijc.33166","article-title":"The genomic profile of parathyroid carcinoma based on whole-genome sequencing","volume":"147","author":"Hu","year":"2020","journal-title":"Int J Cancer"},{"issue":"28","key":"2023091509045933600_bnad009-B262","doi-asserted-by":"crossref","first-page":"4025","DOI":"10.1038\/onc.2017.43","article-title":"Mice deleted for cell division cycle 73 gene develop parathyroid and uterine tumours: model for the hyperparathyroidism-jaw tumour syndrome","volume":"36","author":"Walls","year":"2017","journal-title":"Oncogene"},{"issue":"41","key":"2023091509045933600_bnad009-B263","doi-asserted-by":"crossref","first-page":"6241","DOI":"10.1038\/sj.onc.1208778","article-title":"Identification of a functional bipartite nuclear localization signal in the tumor suppressor parafibromin","volume":"24","author":"Hahn","year":"2005","journal-title":"Oncogene"},{"issue":"8","key":"2023091509045933600_bnad009-B264","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1038\/sj.onc.1209893","article-title":"Parafibromin is a nuclear protein with a functional monopartite nuclear localization signal","volume":"26","author":"Bradley","year":"2007","journal-title":"Oncogene"},{"issue":"2","key":"2023091509045933600_bnad009-B265","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1677\/ERC-09-0272","article-title":"Defective nucleolar localization and dominant interfering properties of a parafibromin L95P missense mutant causing the hyperparathyroidism-jaw tumor syndrome","volume":"17","author":"Panicker","year":"2010","journal-title":"Endocr Relat Cancer"},{"issue":"2","key":"2023091509045933600_bnad009-B266","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1128\/MCB.25.2.612-620.2005","article-title":"The parafibromin tumor suppressor protein is part of a human Paf1 complex","volume":"25","author":"Rozenblatt-Rosen","year":"2005","journal-title":"Mol Cell Biol"},{"issue":"12","key":"2023091509045933600_bnad009-B267","doi-asserted-by":"crossref","first-page":"5052","DOI":"10.1128\/MCB.25.12.5052-5060.2005","article-title":"The HRPT2 tumor suppressor gene product parafibromin associates with human PAF1 and RNA polymerase II","volume":"25","author":"Yart","year":"2005","journal-title":"Mol Cell Biol"},{"issue":"3","key":"2023091509045933600_bnad009-B268","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/humu.21188","article-title":"Cell division cycle protein 73 homolog (CDC73) mutations in the hyperparathyroidism-jaw tumor syndrome (HPT-JT) and parathyroid tumors","volume":"31","author":"Newey","year":"2010","journal-title":"Human mutation"},{"issue":"1","key":"2023091509045933600_bnad009-B269","doi-asserted-by":"crossref","first-page":"15638","DOI":"10.1038\/s41598-017-15715-9","article-title":"Crystal structure of the N-terminal domain of human CDC73 and its implications for the hyperparathyroidism-jaw tumor (HPT-JT) syndrome","volume":"7","author":"Sun","year":"2017","journal-title":"Sci Rep"},{"issue":"14","key":"2023091509045933600_bnad009-B270","doi-asserted-by":"crossref","first-page":"10863","DOI":"10.1074\/jbc.M111.325647","article-title":"Cdc73 subunit of Paf1 complex contains C-terminal Ras-like domain that promotes association of Paf1 complex with chromatin","volume":"287","author":"Amrich","year":"2012","journal-title":"J Biol Chem"},{"issue":"Pt 8","key":"2023091509045933600_bnad009-B271","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1107\/S0907444912017325","article-title":"Crystallographic analysis of the conserved C-terminal domain of transcription factor Cdc73 from Saccharomyces cerevisiae reveals a GTPase-like fold","volume":"68","author":"Chen","year":"2012","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"issue":"42","key":"2023091509045933600_bnad009-B272","doi-asserted-by":"crossref","first-page":"6176","DOI":"10.1038\/sj.onc.1210445","article-title":"Parafibromin tumor suppressor enhances cell growth in the cells expressing SV40 large T antigen","volume":"26","author":"Iwata","year":"2007","journal-title":"Oncogene"},{"issue":"2","key":"2023091509045933600_bnad009-B273","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.cell.2006.01.053","article-title":"Parafibromin\/Hyrax activates Wnt\/Wg target gene transcription by direct association with beta-catenin\/armadillo","volume":"125","author":"Mosimann","year":"2006","journal-title":"Cell"},{"key":"2023091509045933600_bnad009-B274","doi-asserted-by":"crossref","first-page":"12887","DOI":"10.1038\/ncomms12887","article-title":"Dephosphorylated parafibromin is a transcriptional coactivator of the Wnt\/Hedgehog\/Notch pathways","volume":"7","author":"Kikuchi","year":"2016","journal-title":"Nat Commun"},{"issue":"1","key":"2023091509045933600_bnad009-B275","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.molcel.2011.05.014","article-title":"SHP2 tyrosine phosphatase converts parafibromin\/Cdc73 from a tumor suppressor to an oncogenic driver","volume":"43","author":"Takahashi","year":"2011","journal-title":"Mol Cell"},{"key":"2023091509045933600_bnad009-B276","doi-asserted-by":"crossref","first-page":"557050","DOI":"10.3389\/fendo.2020.557050","article-title":"Prevalence of parathyroid carcinoma and atypical parathyroid neoplasms in 153 patients with multiple endocrine neoplasia type 1: case series and literature review","volume":"11","author":"Song","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"6","key":"2023091509045933600_bnad009-B277","doi-asserted-by":"crossref","first-page":"567","DOI":"10.4158\/EP09045.CRR1","article-title":"Parathyroid carcinoma in multiple endocrine neoplasia type 1 with a classic germline mutation","volume":"15","author":"Shih","year":"2009","journal-title":"Endocr Pract"},{"issue":"6","key":"2023091509045933600_bnad009-B278","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1634\/theoncologist.2018-0334","article-title":"Genomic profiling of parathyroid carcinoma reveals genomic alterations suggesting benefit from therapy","volume":"24","author":"Kang","year":"2019","journal-title":"Oncologist"},{"issue":"3","key":"2023091509045933600_bnad009-B279","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1111\/j.1365-2265.2007.02894.x","article-title":"Identification of MEN1 and HRPT2 somatic mutations in paraffin-embedded (sporadic) parathyroid carcinomas","volume":"67","author":"Haven","year":"2007","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"4","key":"2023091509045933600_bnad009-B280","doi-asserted-by":"crossref","first-page":"326","DOI":"10.14310\/horm.2002.1325","article-title":"Parathyroid carcinoma in multiple endocrine neoplasia type 1. Case report and review of the literature","volume":"10","author":"del Pozo","year":"2011","journal-title":"Hormones (Athens)"},{"issue":"2","key":"2023091509045933600_bnad009-B281","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/cen.12714","article-title":"Prevalence of parathyroid carcinoma in 348 patients with multiple endocrine neoplasia type 1\u2014case report and review of the literature","volume":"84","author":"Singh Ospina","year":"2016","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"12","key":"2023091509045933600_bnad009-B282","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1002\/humu.23337","article-title":"Molecular genetics of syndromic and non-syndromic forms of parathyroid carcinoma","volume":"38","author":"Cardoso","year":"2017","journal-title":"Human mutation"},{"issue":"3","key":"2023091509045933600_bnad009-B283","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1002\/ijc.31948","article-title":"Preliminary exploration of potential molecular therapeutic targets in recurrent and metastatic parathyroid carcinomas","volume":"144","author":"Cui","year":"2019","journal-title":"Int J Cancer"},{"issue":"8","key":"2023091509045933600_bnad009-B284","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1007\/s00432-019-02945-9","article-title":"Genetic profiling as a clinical tool in advanced parathyroid carcinoma","volume":"145","author":"Kutahyalioglu","year":"2019","journal-title":"J Cancer Res Clin Oncol"},{"issue":"3","key":"2023091509045933600_bnad009-B285","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/path.4203","article-title":"Complete genomic landscape of a recurring sporadic parathyroid carcinoma","volume":"230","author":"Kasaian","year":"2013","journal-title":"J Pathol"},{"issue":"3","key":"2023091509045933600_bnad009-B286","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1210\/js.2018-00043","article-title":"Comprehensive genomic characterization of parathyroid cancer identifies novel candidate driver mutations and core pathways","volume":"3","author":"Clarke","year":"2019","journal-title":"J Endocr Soc"},{"issue":"7","key":"2023091509045933600_bnad009-B287","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1007\/s00268-014-2455-9","article-title":"Copy number variation in CCND1 gene is implicated in the pathogenesis of sporadic parathyroid carcinoma","volume":"38","author":"Zhao","year":"2014","journal-title":"World J Surg"},{"key":"2023091509045933600_bnad009-B288","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.biopha.2017.05.028","article-title":"Specifying the molecular pattern of sporadic parathyroid tumorigenesis-The Y282D variant of the GCM2 gene","volume":"92","author":"Marchiori","year":"2017","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"2023091509045933600_bnad009-B289","first-page":"103","article-title":"Absence of p53 point mutations in parathyroid adenoma and carcinoma","volume":"78","author":"Hakim","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"2023091509045933600_bnad009-B290","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1046\/j.1440-1827.1999.00961.x","article-title":"Overexpression and genetic abnormality of p53 in parathyroid adenomas","volume":"49","author":"Kishikawa","year":"1999","journal-title":"Pathol Int"},{"issue":"2","key":"2023091509045933600_bnad009-B291","doi-asserted-by":"crossref","first-page":"E360","DOI":"10.1210\/jc.2014-3238","article-title":"Whole-exome sequencing studies of parathyroid carcinomas reveal novel PRUNE2 mutations, distinctive mutational spectra related to APOBEC-catalyzed DNA mutagenesis and mutational enrichment in kinases associated with cell migration and invasion","volume":"100","author":"Yu","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"2023091509045933600_bnad009-B292","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1530\/ERC-17-0009","article-title":"A role for TET2 in parathyroid carcinoma","volume":"24","author":"Barazeghi","year":"2017","journal-title":"Endocr Relat Cancer"},{"issue":"1","key":"2023091509045933600_bnad009-B293","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s12020-016-0892-y","article-title":"EZH2 and ZFX oncogenes in malignant behaviour of parathyroid neoplasms","volume":"54","author":"Sanpaolo","year":"2016","journal-title":"Endocrine"},{"issue":"10","key":"2023091509045933600_bnad009-B294","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1111\/jcmm.12372","article-title":"First evidence of TRPV5 and TRPV6 channels in human parathyroid glands: possible involvement in neoplastic transformation","volume":"18","author":"Giusti","year":"2014","journal-title":"J Cell Mol Med"},{"issue":"2","key":"2023091509045933600_bnad009-B295","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1530\/ERC-13-0497","article-title":"The histone methyltransferase EZH2, an oncogene common to benign and malignant parathyroid tumors","volume":"21","author":"Svedlund","year":"2014","journal-title":"Endocr Relat Cancer"},{"issue":"9","key":"2023091509045933600_bnad009-B296","doi-asserted-by":"crossref","first-page":"3194","DOI":"10.1210\/jcem.81.9.8784068","article-title":"Allelic loss of the retinoblastoma tumor suppressor gene: a marker for aggressive parathyroid tumors?","volume":"81","author":"Dotzenrath","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2023091509045933600_bnad009-B297","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1046\/j.1365-2265.1996.d01-1561.x","article-title":"Loss of heterozygosity studies at the retinoblastoma and breast cancer susceptibility (BRCA2) loci in pituitary, parathyroid, pancreatic and carcinoid tumours","volume":"45","author":"Pearce","year":"1996","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"2023091509045933600_bnad009-B298","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1046\/j.1365-2265.2003.01814.x","article-title":"Mutational analyses of RB and BRCA2 as candidate tumour suppressor genes in parathyroid carcinoma","volume":"59","author":"Shattuck","year":"2003","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"4","key":"2023091509045933600_bnad009-B299","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1006\/bbrc.2002.6338","article-title":"Mammalian fat3: a large protein that contains multiple cadherin and EGF-like motifs","volume":"290","author":"Mitsui","year":"2002","journal-title":"Biochem Biophys Res Commun"},{"issue":"6","key":"2023091509045933600_bnad009-B300","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.3892\/ijo.2012.1669","article-title":"Function and cancer genomics of FAT family genes (review)","volume":"41","author":"Katoh","year":"2012","journal-title":"Int J Oncol"},{"issue":"10","key":"2023091509045933600_bnad009-B301","doi-asserted-by":"crossref","first-page":"e7315","DOI":"10.1371\/journal.pone.0007315","article-title":"Cancer genomics identifies regulatory gene networks associated with the transition from dysplasia to advanced lung adenocarcinomas induced by c-Raf-1","volume":"4","author":"Rohrbeck","year":"2009","journal-title":"PLoS One"},{"key":"2023091509045933600_bnad009-B302","doi-asserted-by":"crossref","first-page":"834362","DOI":"10.3389\/fendo.2022.834362","article-title":"Genetics and epigenetics of parathyroid carcinoma","volume":"13","author":"Marini","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"8010","key":"2023091509045933600_bnad009-B303","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S0140-6736(77)91414-3","article-title":"Parathyroid hyperplasia and parathyromatosis","volume":"1","author":"Reddick","year":"1977","journal-title":"Lancet"},{"issue":"3","key":"2023091509045933600_bnad009-B304","doi-asserted-by":"crossref","first-page":"E45","DOI":"10.1111\/hdi.12525","article-title":"Hyperparathyroidism caused by distant pulmonary lesions and parathyromatosis after ethanol injection\/parathyroidectomy for secondary hyperparathyroidism","volume":"21","author":"Nakamura","year":"2017","journal-title":"Hemodial Int"},{"issue":"3","key":"2023091509045933600_bnad009-B305","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1080\/00015458.2013.11680918","article-title":"Recurrent hyperparathyroidism caused by benign neoplastic seeding: two cases of parathyromatosis and a review of the literature","volume":"113","author":"Twigt","year":"2013","journal-title":"Acta Chir Belg"},{"issue":"2","key":"2023091509045933600_bnad009-B306","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s00268-006-0391-z","article-title":"Recurrent renal hyperparathyroidism caused by parathyromatosis","volume":"31","author":"Matsuoka","year":"2007","journal-title":"World J Surg"},{"issue":"11","key":"2023091509045933600_bnad009-B307","doi-asserted-by":"crossref","first-page":"e443","DOI":"10.1097\/RLU.0b013e318279bc2c","article-title":"(99 m)Tc MIBI SPECT findings in parathyromatosis-a rare entity causing recurrent hyperparathyroidism","volume":"38","author":"Pinnamaneni","year":"2013","journal-title":"Clin Nucl Med"},{"issue":"4","key":"2023091509045933600_bnad009-B308","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/qjmed\/hcac042","article-title":"Parathyromatosis: a challenging cause of recurrent primary hyperparathyroidism","volume":"115","author":"Latg\u00e9","year":"2022","journal-title":"QJM"},{"issue":"3","key":"2023091509045933600_bnad009-B309","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1007\/s12105-020-01281-6","article-title":"Distinguishing parathyromatosis, atypical parathyroid adenomas, and parathyroid carcinomas utilizing histologic and clinical features","volume":"15","author":"Schulte","year":"2021","journal-title":"Head Neck Pathol"},{"issue":"1","key":"2023091509045933600_bnad009-B310","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s42000-021-00343-w","article-title":"Effective long-term management of parathyromatosis-related refractory hypercalcemia with a combination of denosumab and cinacalcet treatment","volume":"21","author":"Tzotzas","year":"2022","journal-title":"Hormones (Athens)"},{"issue":"2","key":"2023091509045933600_bnad009-B311","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s12020-016-1139-7","article-title":"Recurrent primary hyperparathyroidism due to Type 1 parathyromatosis","volume":"55","author":"Jain","year":"2017","journal-title":"Endocrine"},{"issue":"8","key":"2023091509045933600_bnad009-B312","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1001\/archsurg.1975.01360140148028","article-title":"The surgical aspects of hyperparathyroidism","volume":"110","author":"Palmer","year":"1975","journal-title":"Arch Surg"},{"issue":"1","key":"2023091509045933600_bnad009-B313","doi-asserted-by":"crossref","first-page":"e4","DOI":"10.4158\/EP13053.CR","article-title":"Secondary parathyromatosis in a patient with normal kidney function: review of diagnostic modalities and approaches to management","volume":"20","author":"Scorza","year":"2014","journal-title":"Endocr Pract"},{"issue":"6","key":"2023091509045933600_bnad009-B314","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.metabol.2011.11.001","article-title":"Parathyromatosis: a rare yet problematic etiology of recurrent and persistent hyperparathyroidism","volume":"61","author":"Hage","year":"2012","journal-title":"Metabolism"},{"issue":"4","key":"2023091509045933600_bnad009-B315","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1056\/NEJMoa040008","article-title":"Acquired hypocalciuric hypercalcemia due to autoantibodies against the calcium-sensing receptor","volume":"351","author":"Pallais","year":"2004","journal-title":"N Engl J Med"},{"issue":"1","key":"2023091509045933600_bnad009-B316","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1210\/jc.2002-020249","article-title":"A syndrome of hypocalciuric hypercalcemia caused by autoantibodies directed at the calcium-sensing receptor","volume":"88","author":"Kifor","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2023091509045933600_bnad009-B317","doi-asserted-by":"crossref","first-page":"K1","DOI":"10.1530\/EJE-17-0172","article-title":"Glucocorticoid-responsive lymphocytic parathyroiditis and hypocalciuric hypercalcemia due to autoantibodies against the calcium-sensing receptor: a case report and literature review","volume":"177","author":"Song","year":"2017","journal-title":"Eur J Endocrinol"},{"key":"2023091509045933600_bnad009-B318","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.156742","article-title":"Successful prednisolone or calcimimetic treatment of acquired hypocalciuric hypercalcemia caused by biased allosteric CaSR autoantibodies","author":"Makita","year":"2022","journal-title":"JCI Insight"},{"issue":"2","key":"2023091509045933600_bnad009-B319","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s00268-017-4328-5","article-title":"Lithium-associated hypercalcemia: pathophysiology, prevalence, management","volume":"42","author":"Meehan","year":"2018","journal-title":"World J Surg"},{"issue":"5","key":"2023091509045933600_bnad009-B320","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1097\/00000658-200205000-00008","article-title":"Six hundred fifty-six consecutive explorations for primary hyperparathyroidism","volume":"235","author":"Udelsman","year":"2002","journal-title":"Ann Surg"},{"key":"2023091509045933600_bnad009-B321","first-page":"363","article-title":"Genetic aspects of adenomatosis of endocrine glands","volume":"16","author":"Wermer","year":"1954","journal-title":"Am J Med Sci"},{"issue":"7939","key":"2023091509045933600_bnad009-B322","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/S0140-6736(75)80002-X","article-title":"Occurrence of other endocrine tumours in primary hyperparathyroidism","volume":"2","author":"Boey","year":"1975","journal-title":"Lancet"},{"issue":"2","key":"2023091509045933600_bnad009-B323","doi-asserted-by":"crossref","first-page":"233","DOI":"10.3109\/00365528509089663","article-title":"Frequency of endocrine disorders in patients with the Zollinger-Ellison syndrome","volume":"20","author":"Bardram","year":"1985","journal-title":"Scand J Gastroenterol"},{"issue":"5","key":"2023091509045933600_bnad009-B324","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1046\/j.1365-2265.1997.3311122.x","article-title":"Multiple endocrine neoplasia type 1 in patients with recognized pituitary tumours of different types","volume":"47","author":"Corbetta","year":"1997","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"9","key":"2023091509045933600_bnad009-B325","doi-asserted-by":"crossref","first-page":"2990","DOI":"10.1210\/jc.2012-1230","article-title":"Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1)","volume":"97","author":"Thakker","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2023091509045933600_bnad009-B326","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1210\/jc.2014-3670","article-title":"Macroprolactinomas in children and adolescents: factors associated with the response to treatment in 77 patients","volume":"100","author":"Salenave","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"2023091509045933600_bnad009-B327","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1007\/s002680010237","article-title":"Are patients with multiple endocrine neoplasia type I prone to premature death?","volume":"24","author":"Dean","year":"2000","journal-title":"World J Surg"},{"issue":"4","key":"2023091509045933600_bnad009-B328","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1111\/j.1365-2265.2008.03324.x","article-title":"Multiple endocrine neoplasia type 1 (MEN1): its manifestations and effect of genetic screening on clinical outcome","volume":"70","author":"Pieterman","year":"2009","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"6","key":"2023091509045933600_bnad009-B329","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1530\/eje.0.1490577","article-title":"Do patients with multiple endocrine neoplasia syndrome type 1 benefit from periodical screening?","volume":"149","author":"Geerdink","year":"2003","journal-title":"Eur J Endocrinol"},{"issue":"12","key":"2023091509045933600_bnad009-B330","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1007\/s00268-004-7642-7","article-title":"Prospective evaluation of imaging procedures for the detection of pancreaticoduodenal endocrine tumors in patients with multiple endocrine neoplasia type 1","volume":"28","author":"Langer","year":"2004","journal-title":"World J Surg"},{"issue":"5","key":"2023091509045933600_bnad009-B331","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s00268-006-0360-y","article-title":"Management of pancreatic endocrine tumors in multiple endocrine neoplasia type 1","volume":"30","author":"Kouvaraki","year":"2006","journal-title":"World J Surg"},{"issue":"4","key":"2023091509045933600_bnad009-B332","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1111\/j.1365-2265.2007.02934.x","article-title":"Age-related penetrance of endocrine tumours in multiple endocrine neoplasia type 1 (MEN1): a multicentre study of 258 gene carriers","volume":"67","author":"Machens","year":"2007","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2023091509045933600_bnad009-B333","doi-asserted-by":"crossref","first-page":"339","DOI":"10.3389\/fendo.2019.00339","article-title":"Multiple endocrine neoplasia type 1 (MEN1): an update and the significance of early genetic and clinical diagnosis","volume":"10","author":"Kamilaris","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"8","key":"2023091509045933600_bnad009-B334","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1359\/jbmr.090304","article-title":"Sporadic and MEN1-related primary hyperparathyroidism: differences in clinical expression and severity","volume":"24","author":"Eller-Vainicher","year":"2009","journal-title":"J Bone Miner Res"},{"issue":"4","key":"2023091509045933600_bnad009-B335","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1210\/jc.2014-3659","article-title":"MEN1 disease occurring before 21 years old: a 160-patient cohort study from the Groupe d'etude des Tumeurs Endocrines","volume":"100","author":"Goudet","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2023091509045933600_bnad009-B336","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.jpedsurg.2013.11.059","article-title":"Preoperative multiple endocrine neoplasia type 1 diagnosis improves the surgical outcomes of pediatric patients with primary hyperparathyroidism","volume":"49","author":"Romero Arenas","year":"2014","journal-title":"J Pediatr Surg"},{"issue":"6","key":"2023091509045933600_bnad009-B337","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1097\/SLA.0b013e31824c5145","article-title":"Primary hyperparathyroidism in MEN1 patients: a cohort study with longterm follow-up on preferred surgical procedure and the relation with genotype","volume":"255","author":"Pieterman","year":"2012","journal-title":"Ann Surg"},{"issue":"2","key":"2023091509045933600_bnad009-B338","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1245\/s10434-015-4865-9","article-title":"Limited parathyroidectomy in multiple endocrine neoplasia type 1-associated primary hyperparathyroidism: a setup for failure","volume":"23","author":"Nilubol","year":"2016","journal-title":"Ann Surg Oncol"},{"issue":"9","key":"2023091509045933600_bnad009-B339","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1007\/s00268-011-1068-9","article-title":"The optimal surgical treatment for primary hyperparathyroidism in MEN1 patients: a systematic review","volume":"35","author":"Schreinemakers","year":"2011","journal-title":"World J Surg"},{"issue":"10","key":"2023091509045933600_bnad009-B340","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1002\/bjs.7154","article-title":"Surgery for multiple endocrine neoplasia type 1-associated primary hyperparathyroidism","volume":"97","author":"Waldmann","year":"2010","journal-title":"Br J Surg"},{"issue":"4","key":"2023091509045933600_bnad009-B341","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1001\/archsurg.140.4.374","article-title":"Surgical treatment of hyperparathyroidism in patients with multiple endocrine neoplasia type 1","volume":"140","author":"Lambert","year":"2005","journal-title":"Arch Surg"},{"issue":"6","key":"2023091509045933600_bnad009-B342","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1097\/SLA.0b013e31811f4467","article-title":"Is total parathyroidectomy the treatment of choice for hyperparathyroidism in multiple endocrine neoplasia type 1?","volume":"246","author":"Tonelli","year":"2007","journal-title":"Ann Surg"},{"issue":"3","key":"2023091509045933600_bnad009-B343","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1097\/SLA.0b013e31815efda5","article-title":"Prospective study of surgery for primary hyperparathyroidism (HPT) in multiple endocrine neoplasia-type 1 and Zollinger-Ellison syndrome: long-term outcome of a more virulent form of HPT","volume":"247","author":"Norton","year":"2008","journal-title":"Ann Surg"},{"issue":"2","key":"2023091509045933600_bnad009-B344","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.surg.2020.08.021","article-title":"Optimal extent of initial parathyroid resection in patients with multiple endocrine neoplasia syndrome type 1: a meta-analysis","volume":"169","author":"Nastos","year":"2021","journal-title":"Surgery"},{"key":"2023091509045933600_bnad009-B345","doi-asserted-by":"crossref","first-page":"906163","DOI":"10.1155\/2010\/906163","article-title":"Clinical use of cinacalcet in MEN1 hyperparathyroidism","volume":"2010","author":"Moyes","year":"2010","journal-title":"Int J Endocrinol"},{"issue":"3","key":"2023091509045933600_bnad009-B346","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0104-4230(12)70202-6","article-title":"Supernumerary parathyroid glands in hyperparathyroidism associated with multiple endocrine neoplasia type 1","volume":"58","author":"d'Alessandro","year":"2012","journal-title":"Rev Assoc Med Bras (1992)"},{"issue":"4","key":"2023091509045933600_bnad009-B347","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/S0002-9440(10)64406-9","article-title":"Independent genetic events associated with the development of multiple parathyroid tumors in patients with primary hyperparathyroidism","volume":"161","author":"Dwight","year":"2002","journal-title":"Am J Pathol"},{"issue":"22","key":"2023091509045933600_bnad009-B348","first-page":"5272","article-title":"Allelic deletions on chromosome 11q13 in multiple tumors from individual MEN1 patients","volume":"56","author":"Lubensky","year":"1996","journal-title":"Cancer Res"},{"issue":"4","key":"2023091509045933600_bnad009-B349","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1056\/NEJM198907273210402","article-title":"Clonality of parathyroid tumors in familial multiple endocrine neoplasia type 1","volume":"321","author":"Friedman","year":"1989","journal-title":"N Engl J Med"},{"issue":"6","key":"2023091509045933600_bnad009-B350","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1507\/endocrj.EJ12-0306","article-title":"A large functioning parathyroid cyst in a patient with multiple endocrine neoplasia type 1","volume":"60","author":"Tamiya","year":"2013","journal-title":"Endocr J"},{"issue":"8","key":"2023091509045933600_bnad009-B351","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1530\/EC-17-0207","article-title":"MEN1 gene mutation with parathyroid carcinoma: first report of a familial case","volume":"6","author":"Cinque","year":"2017","journal-title":"Endocr Connect"},{"issue":"2","key":"2023091509045933600_bnad009-B352","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1210\/jcem.87.2.8145","article-title":"Pituitary disease in MEN type 1 (MEN1): data from the France-Belgium MEN1 multicenter study","volume":"87","author":"Verges","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2023091509045933600_bnad009-B353","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1097\/PAS.0b013e31815ade45","article-title":"Pituitary tumors and hyperplasia in multiple endocrine neoplasia type 1 syndrome (MEN1): a case-control study in a series of 77 patients versus 2509 non-MEN1 patients","volume":"32","author":"Trouillas","year":"2008","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"2023091509045933600_bnad009-B354","first-page":"1132","article-title":"Pituitary adenomas in the setting of multiple endocrine neoplasia type 1: a single-institution experience","volume":"134","author":"Cohen-Cohen","year":"2020","journal-title":"J Neurosurg"},{"key":"2023091509045933600_bnad009-B355","doi-asserted-by":"crossref","first-page":"582","DOI":"10.3389\/fendo.2019.00582","article-title":"Giant prolactinoma causing hydrocephalus and intracranial hypertension as first manifestations of multiple endocrine neoplasia type 1","volume":"10","author":"Dantas","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"12","key":"2023091509045933600_bnad009-B356","first-page":"4776","article-title":"Pituitary macroadenoma in a 5-year-old: an early expression of multiple endocrine neoplasia type 1","volume":"85","author":"Stratakis","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2023091509045933600_bnad009-B357","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1530\/eje.0.1510709","article-title":"Cushing's disease in childhood as the first manifestation of multiple endocrine neoplasia syndrome type 1","volume":"151","author":"Rix","year":"2004","journal-title":"Eur J Endocrinol"},{"issue":"7","key":"2023091509045933600_bnad009-B358","first-page":"2642","article-title":"Spectrum of pituitary disease in multiple endocrine neoplasia type 1 (MEN 1): clinical, biochemical, and radiological features of pituitary disease in a large MEN 1 kindred","volume":"81","author":"Burgess","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2023091509045933600_bnad009-B359","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.humpath.2008.06.013","article-title":"Multiple endocrine neoplasia type 1-associated thyrotropin-producing pituitary carcinoma: report of a probable de novo example","volume":"40","author":"Scheithauer","year":"2009","journal-title":"Hum Pathol"},{"issue":"3","key":"2023091509045933600_bnad009-B360","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/j.1365-2265.2011.04220.x","article-title":"Cushing's syndrome in multiple endocrine neoplasia type 1","volume":"76","author":"Simonds","year":"2012","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"3","key":"2023091509045933600_bnad009-B361","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/j.1365-2265.2009.03667.x","article-title":"Prevalence of pituitary adenomas: a community-based, cross-sectional study in Banbury (Oxfordshire, UK)","volume":"72","author":"Fernandez","year":"2010","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"11","key":"2023091509045933600_bnad009-B362","doi-asserted-by":"crossref","first-page":"3933","DOI":"10.1210\/jc.2014-2700","article-title":"Acromegaly: an endocrine society clinical practice guideline","volume":"99","author":"Katznelson","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2023091509045933600_bnad009-B363","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1210\/jc.2010-1692","article-title":"Diagnosis and treatment of hyperprolactinemia: an Endocrine Society clinical practice guideline","volume":"96","author":"Melmed","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"2023091509045933600_bnad009-B364","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1210\/jc.2015-1818","article-title":"Treatment of Cushing's syndrome: an Endocrine Society clinical practice guideline","volume":"100","author":"Nieman","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"2023091509045933600_bnad009-B365","doi-asserted-by":"crossref","first-page":"3776","DOI":"10.1210\/jc.2003-031511","article-title":"Multiple endocrine neoplasia type 1 variant with frequent prolactinoma and rare gastrinoma","volume":"89","author":"Hao","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2023091509045933600_bnad009-B366","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1002\/(SICI)1098-1004(1998)11:4<264::AID-HUMU2>3.0.CO;2-V","article-title":"Common ancestral mutation in the MEN1 gene is likely responsible for the prolactinoma variant of MEN1 (MEN1Burin) in four kindreds from Newfoundland","volume":"11","author":"Olufemi","year":"1998","journal-title":"Human mutation"},{"issue":"2","key":"2023091509045933600_bnad009-B367","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1046\/j.1365-2265.2000.01032.x","article-title":"Phenotype and phenocopy: the relationship between genotype and clinical phenotype in a single large family with multiple endocrine neoplasia type 1 (MEN 1)","volume":"53","author":"Burgess","year":"2000","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"6","key":"2023091509045933600_bnad009-B368","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1046\/j.1365-2796.2003.01164.x","article-title":"The treatment of sporadic versus MEN1-related pituitary adenomas","volume":"253","author":"Beckers","year":"2003","journal-title":"J Intern Med"},{"issue":"2","key":"2023091509045933600_bnad009-B369","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/j.1572-0241.2006.00367.x","article-title":"Prospective endoscopic ultrasonographic evaluation of the frequency of nonfunctioning pancreaticoduodenal endocrine tumors in patients with multiple endocrine neoplasia type 1","volume":"101","author":"Thomas-Marques","year":"2006","journal-title":"Am J Gastroenterol"},{"issue":"10","key":"2023091509045933600_bnad009-B370","doi-asserted-by":"crossref","first-page":"3640","DOI":"10.1210\/jc.2009-0564","article-title":"Asymptomatic children with multiple endocrine neoplasia type 1 mutations may harbor nonfunctioning pancreatic neuroendocrine tumors","volume":"94","author":"Newey","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2023091509045933600_bnad009-B371","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s00268-009-0290-1","article-title":"Risk factors and causes of death in MEN1 disease. A GTE (Groupe d'Etude des Tumeurs Endocrines) cohort study among 758 patients","volume":"34","author":"Goudet","year":"2010","journal-title":"World J Surg"},{"issue":"34","key":"2023091509045933600_bnad009-B372","doi-asserted-by":"crossref","first-page":"5440","DOI":"10.3748\/wjg.v12.i34.5440","article-title":"Sporadic versus hereditary gastrinomas of the duodenum and pancreas: distinct clinico-pathological and epidemiological features","volume":"12","author":"Anlauf","year":"2006","journal-title":"World J Gastroenterol"},{"issue":"2","key":"2023091509045933600_bnad009-B373","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/S0016-5085(99)70124-1","article-title":"Prognostic factors in patients with Zollinger-Ellison syndrome and multiple endocrine neoplasia type 1. Groupe d'Etude des Neoplasies Endocriniennes Multiples (GENEM and groupe de Recherche et d'Etude du Syndrome de Zollinger-Ellison (GRESZE)","volume":"116","author":"Cadiot","year":"1999","journal-title":"Gastroenterology"},{"issue":"6","key":"2023091509045933600_bnad009-B374","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1097\/SLA.0000000000003162","article-title":"Metastatic potential and survival of duodenal and pancreatic tumors in multiple endocrine neoplasia type 1: a GTE and AFCE cohort study (Groupe d'etude des tumeurs endocrines and association francophone de chirurgie endocrinienne)","volume":"272","author":"Vinault","year":"2020","journal-title":"Ann Surg"},{"issue":"6","key":"2023091509045933600_bnad009-B375","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1002\/jso.25667","article-title":"Prognostic factors and survival in MEN1 patients with gastrinomas: results from the DutchMEN study group (DMSG)","volume":"120","author":"van Beek","year":"2019","journal-title":"J Surg Oncol"},{"issue":"11","key":"2023091509045933600_bnad009-B376","doi-asserted-by":"crossref","first-page":"5282","DOI":"10.1210\/jcem.86.11.8011","article-title":"Prospective study of the natural history of gastrinoma in patients with MEN1: definition of an aggressive and a nonaggressive form","volume":"86","author":"Gibril","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2023091509045933600_bnad009-B377","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/01.md.0000112297.72510.32","article-title":"Multiple endocrine neoplasia type 1 and Zollinger-Ellison syndrome: a prospective study of 107 cases and comparison with 1009 cases from the literature","volume":"83","author":"Gibril","year":"2004","journal-title":"Medicine (Baltimore)"},{"issue":"7","key":"2023091509045933600_bnad009-B378","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/S0025-6196(12)62083-7","article-title":"Functioning insulinoma-incidence, recurrence, and long-term survival of patients: a 60-year study","volume":"66","author":"Service","year":"1991","journal-title":"Mayo Clin Proc"},{"issue":"8","key":"2023091509045933600_bnad009-B379","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/ncpendmet0263","article-title":"Recurrent hyperinsulinemic hypoglycemia caused by an insulin-secreting insulinoma","volume":"2","author":"Service","year":"2006","journal-title":"Nat Clin Pract Endocrinol Metab"},{"issue":"3","key":"2023091509045933600_bnad009-B380","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1210\/jc.2008-1410","article-title":"Evaluation and management of adult hypoglycemic disorders: an Endocrine Society Clinical Practice Guideline","volume":"94","author":"Cryer","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2023091509045933600_bnad009-B381","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/01.sla.0000197715.96762.68","article-title":"Epidemiology data on 108 MEN 1 patients from the GTE with isolated nonfunctioning tumors of the pancreas","volume":"243","author":"Triponez","year":"2006","journal-title":"Ann Surg"},{"issue":"5","key":"2023091509045933600_bnad009-B382","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1097\/01.pas.0000194044.01104.25","article-title":"Microadenomatosis of the endocrine pancreas in patients with and without the multiple endocrine neoplasia type 1 syndrome","volume":"30","author":"Anlauf","year":"2006","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"2023091509045933600_bnad009-B383","doi-asserted-by":"crossref","first-page":"E89","DOI":"10.1210\/jc.2013-1768","article-title":"Penetrance of functioning and nonfunctioning pancreatic neuroendocrine tumors in multiple endocrine neoplasia type 1 in the second decade of life","volume":"99","author":"Goncalves","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"2023091509045933600_bnad009-B384","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1007\/s00268-004-7609-8","article-title":"Surgery of resectable nonfunctioning neuroendocrine pancreatic tumors","volume":"28","author":"Dralle","year":"2004","journal-title":"World J Surg"},{"issue":"5","key":"2023091509045933600_bnad009-B385","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1097\/MCG.0000000000000062","article-title":"Long-term follow-up of asymptomatic pancreatic neuroendocrine tumors in multiple endocrine neoplasia type I syndrome","volume":"48","author":"D'Souza S","year":"2014","journal-title":"J Clin Gastroenterol"},{"issue":"6","key":"2023091509045933600_bnad009-B386","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1097\/SLA.0000000000002183","article-title":"Management of MEN1 related nonfunctioning pancreatic NETs: a shifting paradigm: results from the Dutch MEN1 study group","volume":"267","author":"Nell","year":"2018","journal-title":"Ann Surg"},{"issue":"6","key":"2023091509045933600_bnad009-B387","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1159\/000443613","article-title":"Active surveillance versus surgery of nonfunctioning pancreatic neuroendocrine neoplasms \u22642 cm in MEN1 patients","volume":"103","author":"Partelli","year":"2016","journal-title":"Neuroendocrinology"},{"issue":"5","key":"2023091509045933600_bnad009-B388","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1007\/s00268-005-0354-9","article-title":"Is surgery beneficial for MEN1 patients with small (&lt; or = 2 cm), nonfunctioning pancreaticoduodenal endocrine tumor? An analysis of 65 patients from the GTE","volume":"30","author":"Triponez","year":"2006","journal-title":"World J Surg"},{"issue":"10","key":"2023091509045933600_bnad009-B389","doi-asserted-by":"crossref","first-page":"3795","DOI":"10.1210\/jc.2017-00372","article-title":"Long-term natural course of small nonfunctional pancreatic neuroendocrine tumors in MEN1-results from the Dutch MEN1 study group","volume":"102","author":"Pieterman","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2023091509045933600_bnad009-B390","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1097\/01.sla.0000189549.51913.d8","article-title":"Outcome of duodenopancreatic resections in patients with multiple endocrine neoplasia type 1","volume":"242","author":"Bartsch","year":"2005","journal-title":"Ann Surg"},{"issue":"12","key":"2023091509045933600_bnad009-B391","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1634\/theoncologist.2008-0207","article-title":"Carcinoid tumors","volume":"13","author":"Pinchot","year":"2008","journal-title":"Oncologist"},{"issue":"1","key":"2023091509045933600_bnad009-B392","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.athoracsur.2004.07.084","article-title":"ACTH-secreting thymic carcinoid associated with multiple endocrine neoplasia type 1","volume":"81","author":"Yano","year":"2006","journal-title":"Ann Thorac Surg"},{"issue":"4","key":"2023091509045933600_bnad009-B393","doi-asserted-by":"crossref","first-page":"e92","DOI":"10.4158\/EP11038.CR","article-title":"Cushing syndrome secondary to a thymic carcinoid tumor due to multiple endocrine neoplasia type 1","volume":"17","author":"Ghazi","year":"2011","journal-title":"Endocr Pract"},{"issue":"1","key":"2023091509045933600_bnad009-B394","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s12020-013-0141-6","article-title":"Familial Cushing syndrome due to thymic carcinoids in a multiple endocrine neoplasia type 1 kindred","volume":"47","author":"Li","year":"2014","journal-title":"Endocrine"},{"issue":"4","key":"2023091509045933600_bnad009-B395","first-page":"171","article-title":"Resected invasive thymoma with multiple endocrine neoplasia type 1","volume":"54","author":"Kojima","year":"2006","journal-title":"Jpn J Thorac Cardiovasc Surg"},{"issue":"4","key":"2023091509045933600_bnad009-B396","doi-asserted-by":"crossref","first-page":"rjx071","DOI":"10.1093\/jscr\/rjx071","article-title":"Thymoma (World Health Organization type B3) with neuroendocrine differentiation in multiple endocrine neoplasia type 1","volume":"2017","author":"Tomita","year":"2017","journal-title":"J Surg Case Rep"},{"issue":"4","key":"2023091509045933600_bnad009-B397","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/S0046-8177(98)90112-5","article-title":"Neuroendocrine differentiation in thymic epithelial tumors with special reference to thymic carcinoma and atypical thymoma","volume":"29","author":"Hishima","year":"1998","journal-title":"Hum Pathol"},{"issue":"11","key":"2023091509045933600_bnad009-B398","doi-asserted-by":"crossref","first-page":"L15","DOI":"10.1530\/ERC-21-0226","article-title":"Two distinct classes of thymic tumors in patients with MEN1 show LOH at the MEN1 locus","volume":"28","author":"Mandl","year":"2021","journal-title":"Endocr Relat Cancer"},{"issue":"1","key":"2023091509045933600_bnad009-B399","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/00005792-199701000-00002","article-title":"Clinicopathologic studies of thymic carcinoids in multiple endocrine neoplasia type 1","volume":"76","author":"Teh","year":"1997","journal-title":"Medicine (Baltimore)"},{"issue":"6","key":"2023091509045933600_bnad009-B400","first-page":"825","article-title":"Thymic Carcinoid as the First Manifestation of Multiple Endocrine Neoplasia Type 1 Syndrome: a Case Report and Review of the Literature","volume":"50","author":"Zheng","year":"2020","journal-title":"Ann Clin Lab Sci"},{"issue":"2","key":"2023091509045933600_bnad009-B401","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s10689-013-9692-1","article-title":"Ectopic Cushing syndrome associated with thymic carcinoid tumor as the first presentation of MEN1 syndrome-report of a family with MEN1 gene mutation","volume":"13","author":"Hasani-Ranjbar","year":"2014","journal-title":"Fam Cancer"},{"issue":"6","key":"2023091509045933600_bnad009-B402","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1007\/s00268-009-9980-y","article-title":"Thymic neuroendocrine tumors in multiple endocrine neoplasia type 1: a comparative study on 21 cases among a series of 761 MEN1 from the GTE (Groupe des Tumeurs Endocrines)","volume":"33","author":"Goudet","year":"2009","journal-title":"World J Surg"},{"issue":"4","key":"2023091509045933600_bnad009-B403","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s12672-016-0269-y","article-title":"Clinical features, treatments, and outcomes of patients with thymic carcinoids and multiple endocrine neoplasia type 1 syndrome at MD Anderson Cancer Center","volume":"7","author":"Christakis","year":"2016","journal-title":"Horm Cancer"},{"issue":"9","key":"2023091509045933600_bnad009-B404","doi-asserted-by":"crossref","first-page":"3325","DOI":"10.1210\/jc.2014-1560","article-title":"Natural course and survival of neuroendocrine tumors of thymus and lung in MEN1 patients","volume":"99","author":"de Laat","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"5-6","key":"2023091509045933600_bnad009-B405","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s12672-015-0228-z","article-title":"Thymic and bronchial carcinoid tumors in multiple endocrine neoplasia type 1: the mayo clinic experience from 1977 to 2013","volume":"6","author":"Singh Ospina","year":"2015","journal-title":"Horm Cancer"},{"issue":"5","key":"2023091509045933600_bnad009-B406","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1046\/j.1365-2265.2001.01348.x","article-title":"Malignant thymic carcinoid is not prevented by transcervical thymectomy in multiple endocrine neoplasia type 1","volume":"55","author":"Burgess","year":"2001","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"4","key":"2023091509045933600_bnad009-B407","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/j.1365-2796.2006.01619.x","article-title":"Thymic carcinoid in multiple endocrine neoplasia 1: genotype-phenotype correlation and prevention","volume":"259","author":"Lim","year":"2006","journal-title":"J Intern Med"},{"issue":"5","key":"2023091509045933600_bnad009-B408","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1210\/jc.2004-1155","article-title":"Thymic neuroendocrine carcinoma (carcinoid) in multiple endocrine neoplasia type 1 syndrome: the Italian series","volume":"90","author":"Ferolla","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2023091509045933600_bnad009-B409","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1210\/jc.2002-021314","article-title":"Prospective study of thymic carcinoids in patients with multiple endocrine neoplasia type 1","volume":"88","author":"Gibril","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"issue":"3-4","key":"2023091509045933600_bnad009-B410","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1159\/000435921","article-title":"Bronchopulmonary neuroendocrine neoplasms and their precursor lesions in multiple endocrine neoplasia type 1","volume":"103","author":"Bartsch","year":"2016","journal-title":"Neuroendocrinology"},{"issue":"1","key":"2023091509045933600_bnad009-B411","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s00268-017-4135-z","article-title":"histologically proven bronchial neuroendocrine tumors in MEN1: a GTE 51-case cohort study","volume":"42","author":"Lecomte","year":"2018","journal-title":"World J Surg"},{"issue":"3","key":"2023091509045933600_bnad009-B412","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1002\/cncr.20825","article-title":"Bronchopulmonary carcinoid in multiple endocrine neoplasia type 1","volume":"103","author":"Sachithanandan","year":"2005","journal-title":"Cancer"},{"issue":"2","key":"2023091509045933600_bnad009-B413","doi-asserted-by":"crossref","first-page":"e1014","DOI":"10.1210\/clinem\/dgaa800","article-title":"The management of neuroendocrine tumors of the lung in MEN1: results from the Dutch MEN1 study group","volume":"106","author":"van den Broek","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"issue":"13","key":"2023091509045933600_bnad009-B414","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1093\/hmg\/6.13.2285","article-title":"Identification of MEN1 gene mutations in sporadic carcinoid tumors of the lung","volume":"6","author":"Debelenko","year":"1997","journal-title":"Hum Mol Genet"},{"issue":"2","key":"2023091509045933600_bnad009-B415","doi-asserted-by":"crossref","first-page":"E374","DOI":"10.1210\/jc.2013-2782","article-title":"MEN1 gene mutation and reduced expression are associated with poor prognosis in pulmonary carcinoids","volume":"99","author":"Swarts","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2023091509045933600_bnad009-B416","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1530\/EJE-11-0679","article-title":"Adrenal involvement in MEN1. Analysis of 715 cases from the Groupe d'Etude des Tumeurs Endocrines database","volume":"166","author":"Gatta-Cherifi","year":"2012","journal-title":"Eur J Endocrinol"},{"issue":"8","key":"2023091509045933600_bnad009-B417","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1007\/s00268-002-6492-4","article-title":"Adrenal involvement in multiple endocrine neoplasia type 1","volume":"26","author":"Langer","year":"2002","journal-title":"World J Surg"},{"issue":"1","key":"2023091509045933600_bnad009-B418","first-page":"216","article-title":"MEN1 gene analysis in sporadic adrenocortical neoplasms","volume":"84","author":"Heppner","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2023091509045933600_bnad009-B419","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1530\/EJE-07-0635","article-title":"Natural course of small adrenal lesions in multiple endocrine neoplasia type 1: an endoscopic ultrasound imaging study","volume":"158","author":"Schaefer","year":"2008","journal-title":"Eur J Endocrinol"},{"issue":"7","key":"2023091509045933600_bnad009-B420","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1001\/archderm.1997.03890430067009","article-title":"Multiple facial angiofibromas and collagenomas in patients with multiple endocrine neoplasia type 1","volume":"133","author":"Darling","year":"1997","journal-title":"Arch Dermatol"},{"issue":"2","key":"2023091509045933600_bnad009-B421","first-page":"274","article-title":"Perivascular cells harboring multiple endocrine neoplasia type 1 alterations are neoplastic cells in angiofibromas","volume":"59","author":"Vortmeyer","year":"1999","journal-title":"Cancer Res"},{"issue":"5","key":"2023091509045933600_bnad009-B422","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1507\/endocrj.47.569","article-title":"Frequency of facial angiofibromas in Japanese patients with multiple endocrine neoplasia type 1","volume":"47","author":"Sakurai","year":"2000","journal-title":"Endocr J"},{"issue":"11","key":"2023091509045933600_bnad009-B423","doi-asserted-by":"crossref","first-page":"5328","DOI":"10.1210\/jc.2004-0218","article-title":"Cutaneous tumors in patients with multiple endocrine neoplasm type 1 (MEN1) and gastrinomas: prospective study of frequency and development of criteria with high sensitivity and specificity for MEN1","volume":"89","author":"Asgharian","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"2023091509045933600_bnad009-B424","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1111\/j.1468-3083.2008.02578.x","article-title":"Cutaneous lesions associated to multiple endocrine neoplasia syndrome type 1","volume":"22","author":"Vidal","year":"2008","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"9","key":"2023091509045933600_bnad009-B425","doi-asserted-by":"crossref","DOI":"10.5070\/D3209023911","article-title":"Incidental angiofibromas prompt a diagnosis of multiple endocrine neoplasia type-1 (MEN-1)","volume":"20","author":"Roman","year":"2014","journal-title":"Dermatol Online J"},{"issue":"3","key":"2023091509045933600_bnad009-B426","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1158\/1078-0432.CCR-0938-3","article-title":"Meningiomas may be a component tumor of multiple endocrine neoplasia type 1","volume":"10","author":"Asgharian","year":"2004","journal-title":"Clin Cancer Res"},{"issue":"4","key":"2023091509045933600_bnad009-B427","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1007\/s10434-001-0342-8","article-title":"Genetic analysis of a papillary thyroid carcinoma in a patient with MEN1","volume":"8","author":"Desai","year":"2001","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"2023091509045933600_bnad009-B428","doi-asserted-by":"crossref","first-page":"E611","DOI":"10.1210\/jc.2014-3622","article-title":"MEN1 mutations in Hurthle cell (oncocytic) thyroid carcinoma","volume":"100","author":"Kasaian","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2023091509045933600_bnad009-B429","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/S0002-9440(10)61788-9","article-title":"Multiple leiomyomas of the esophagus, lung, and uterus in multiple endocrine neoplasia type 1","volume":"159","author":"McKeeby","year":"2001","journal-title":"Am J Pathol"},{"issue":"6","key":"2023091509045933600_bnad009-B430","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/j.1440-1827.2004.01642.x","article-title":"Ureteral leiomyoma causing hydronephrosis in Type 1 multiple endocrine neoplasia","volume":"54","author":"Ikota","year":"2004","journal-title":"Pathol Int"},{"issue":"6","key":"2023091509045933600_bnad009-B431","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1056\/NEJMc1406028","article-title":"International Breast Cancer in MENSG. Breast-cancer predisposition in multiple endocrine neoplasia type 1","volume":"371","author":"Dreijerink","year":"2014","journal-title":"N Engl J Med"},{"issue":"3","key":"2023091509045933600_bnad009-B432","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/cen.12614","article-title":"Breast cancer risk in MEN1\u2014a cancer genetics perspective","volume":"82","author":"Brennan","year":"2015","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"6","key":"2023091509045933600_bnad009-B433","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1210\/jc.2016-3690","article-title":"MEN1-dependent breast cancer: indication for early screening? Results from the Dutch MEN1 study group","volume":"102","author":"van Leeuwaarde","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2023091509045933600_bnad009-B434","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.3390\/cancers12051171","article-title":"APC mutation marks an aggressive subtype of BRAF mutant colorectal cancers","volume":"12","author":"Fennell","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"5","key":"2023091509045933600_bnad009-B435","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1001\/jamaoncol.2020.0197","article-title":"Frequency of pathogenic germline variants in cancer-susceptibility genes in patients with osteosarcoma","volume":"6","author":"Mirabello","year":"2020","journal-title":"JAMA Oncol"},{"issue":"9","key":"2023091509045933600_bnad009-B436","doi-asserted-by":"crossref","first-page":"3389","DOI":"10.1210\/jc.2007-0476","article-title":"Clinical testing for mutations in the MEN1 gene in Sweden: a report on 200 unrelated cases","volume":"92","author":"Tham","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"2023091509045933600_bnad009-B437","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/humu.10092","article-title":"Germline mutation profile of MEN1 in multiple endocrine neoplasia type 1: search for correlation between phenotype and the functional domains of the MEN1 protein","volume":"20","author":"Wautot","year":"2002","journal-title":"Human mutation"},{"issue":"1","key":"2023091509045933600_bnad009-B438","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1186\/s12916-016-0708-1","article-title":"MEN1 redefined, a clinical comparison of mutation-positive and mutation-negative patients","volume":"14","author":"de Laat","year":"2016","journal-title":"BMC Med"},{"issue":"1","key":"2023091509045933600_bnad009-B439","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.surg.2020.04.067","article-title":"Understanding the clinical course of genotype-negative MEN1 patients can inform management strategies","volume":"169","author":"Pieterman","year":"2021","journal-title":"Surgery"},{"issue":"3","key":"2023091509045933600_bnad009-B440","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1073\/pnas.98.3.1118","article-title":"A mouse model of multiple endocrine neoplasia, type 1, develops multiple endocrine tumors","volume":"98","author":"Crabtree","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"2023091509045933600_bnad009-B441","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S0925-4773(03)00039-X","article-title":"Genetic ablation of the tumor suppressor menin causes lethality at mid-gestation with defects in multiple organs","volume":"120","author":"Bertolino","year":"2003","journal-title":"Mech Dev"},{"issue":"9","key":"2023091509045933600_bnad009-B442","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1210\/me.2003-0154","article-title":"Heterozygous Men1 mutant mice develop a range of endocrine tumors mimicking multiple endocrine neoplasia type 1","volume":"17","author":"Bertolino","year":"2003","journal-title":"Mol Endocrinol"},{"issue":"4","key":"2023091509045933600_bnad009-B443","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1677\/ERC-09-0082","article-title":"Multiple endocrine neoplasia type 1 knockout mice develop parathyroid, pancreatic, pituitary and adrenal tumours with hypercalcaemia, hypophosphataemia and hypercorticosteronaemia","volume":"16","author":"Harding","year":"2009","journal-title":"Endocr Relat Cancer"},{"issue":"2","key":"2023091509045933600_bnad009-B444","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1002\/ijc.22288","article-title":"Broad tumor spectrum in a mouse model of multiple endocrine neoplasia type 1","volume":"120","author":"Loffler","year":"2007","journal-title":"Int J Cancer"},{"issue":"27","key":"2023091509045933600_bnad009-B445","doi-asserted-by":"crossref","first-page":"4009","DOI":"10.1038\/sj.onc.1210163","article-title":"Lack of augmentation of tumor spectrum or severity in dual heterozygous Men1 and Rb1 knockout mice","volume":"26","author":"Loffler","year":"2007","journal-title":"Oncogene"},{"issue":"3","key":"2023091509045933600_bnad009-B446","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1093\/carcin\/bgm207","article-title":"Cell lineage-specific interactions between Men1 and Rb in neuroendocrine neoplasia","volume":"29","author":"Matoso","year":"2008","journal-title":"Carcinogenesis"},{"key":"2023091509045933600_bnad009-B447","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1186\/1471-2407-12-252","article-title":"Menin and p53 have non-synergistic effects on tumorigenesis in mice","volume":"12","author":"Loffler","year":"2012","journal-title":"BMC Cancer"},{"issue":"7","key":"2023091509045933600_bnad009-B448","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1038\/onc.2014.3","article-title":"MEN1 tumorigenesis in the pituitary and pancreatic islet requires Cdk4 but not Cdk2","volume":"34","author":"Gillam","year":"2015","journal-title":"Oncogene"},{"issue":"4","key":"2023091509045933600_bnad009-B449","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1128\/MCB.01764-06","article-title":"p18Ink4c, but not p27Kip1, collaborates with Men1 to suppress neuroendocrine organ tumors","volume":"27","author":"Bai","year":"2007","journal-title":"Mol Cell Biol"},{"issue":"11","key":"2023091509045933600_bnad009-B450","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1007\/s00335-004-2395-z","article-title":"Homozygous loss of menin is well tolerated in liver, a tissue not affected in MEN1","volume":"15","author":"Scacheri","year":"2004","journal-title":"Mamm Genome"},{"issue":"5","key":"2023091509045933600_bnad009-B451","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1158\/0008-5472.CAN-08-3662","article-title":"Recapitulation of pancreatic neuroendocrine tumors in human multiple endocrine neoplasia type I syndrome via Pdx1-directed inactivation of Men1","volume":"69","author":"Shen","year":"2009","journal-title":"Cancer Res"},{"issue":"8","key":"2023091509045933600_bnad009-B452","doi-asserted-by":"crossref","first-page":"4024","DOI":"10.1210\/en.2009-1251","article-title":"Multiple endocrine neoplasia type 1 deletion in pancreatic alpha-cells leads to development of insulinomas in mice","volume":"151","author":"Shen","year":"2010","journal-title":"Endocrinology"},{"issue":"5","key":"2023091509045933600_bnad009-B453","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1053\/j.gastro.2010.01.046","article-title":"Alpha cell-specific Men1 ablation triggers the transdifferentiation of glucagon-expressing cells and insulinoma development","volume":"138","author":"Lu","year":"2010","journal-title":"Gastroenterology"},{"issue":"16","key":"2023091509045933600_bnad009-B454","first-page":"4836","article-title":"Pancreatic beta-cell-specific ablation of the multiple endocrine neoplasia type 1 (MEN1) gene causes full penetrance of insulinoma development in mice","volume":"63","author":"Bertolino","year":"2003","journal-title":"Cancer Res"},{"issue":"8","key":"2023091509045933600_bnad009-B455","doi-asserted-by":"crossref","first-page":"3125","DOI":"10.1128\/MCB.24.8.3125-3131.2004","article-title":"Conditional inactivation of the MEN1 gene leads to pancreatic and pituitary tumorigenesis but does not affect normal development of these tissues","volume":"24","author":"Biondi","year":"2004","journal-title":"Mol Cell Biol"},{"issue":"17","key":"2023091509045933600_bnad009-B456","doi-asserted-by":"crossref","first-page":"6075","DOI":"10.1128\/MCB.23.17.6075-6085.2003","article-title":"Of mice and MEN1: Insulinomas in a conditional mouse knockout","volume":"23","author":"Crabtree","year":"2003","journal-title":"Mol Cell Biol"},{"issue":"2","key":"2023091509045933600_bnad009-B457","first-page":"301","article-title":"Differentially expressed genes in Men1 knockout and wildtype embryoid bodies for pancreatic islet development","volume":"4","author":"Zhang","year":"2011","journal-title":"Mol Med Rep"},{"issue":"6","key":"2023091509045933600_bnad009-B458","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1530\/ERC-13-0164","article-title":"Altered MENIN expression disrupts the MAFA differentiation pathway in insulinoma","volume":"20","author":"Hamze","year":"2013","journal-title":"Endocr Relat Cancer"},{"issue":"31","key":"2023091509045933600_bnad009-B459","doi-asserted-by":"crossref","first-page":"3647","DOI":"10.1038\/onc.2011.538","article-title":"Reexpression of oncoprotein MafB in proliferative beta-cells and Men1 insulinomas in mouse","volume":"31","author":"Lu","year":"2012","journal-title":"Oncogene"},{"issue":"1","key":"2023091509045933600_bnad009-B460","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1530\/ERC-12-0077","article-title":"The embryonic transcription factor Hlxb9 is a menin interacting partner that controls pancreatic beta-cell proliferation and the expression of insulin regulators","volume":"20","author":"Shi","year":"2013","journal-title":"Endocr Relat Cancer"},{"issue":"6","key":"2023091509045933600_bnad009-B461","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1089\/thy.2014.0335","article-title":"American Thyroid Association Guidelines Task Force on Medullary Thyroid C. Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma","volume":"25","author":"Wells SA","year":"2015","journal-title":"Thyroid"},{"issue":"6","key":"2023091509045933600_bnad009-B462","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1530\/EC-20-0163","article-title":"Primary hyperparathyroidism as first manifestation in multiple endocrine neoplasia type 2A: an international multicenter study","volume":"9","author":"Larsen","year":"2020","journal-title":"Endocr Connect"},{"issue":"6","key":"2023091509045933600_bnad009-B463","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/S0039-6060(96)80042-0","article-title":"Surgical management of hyperparathyroidism in patients with multiple endocrine neoplasia type 2A","volume":"120","author":"Herfarth","year":"1996","journal-title":"Surgery"},{"issue":"1","key":"2023091509045933600_bnad009-B464","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/humu.21385","article-title":"Risk profiles and penetrance estimations in multiple endocrine neoplasia type 2A caused by germline RET mutations located in exon 10","volume":"32","author":"Frank-Raue","year":"2011","journal-title":"Human mutation"},{"issue":"4","key":"2023091509045933600_bnad009-B465","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/j.1440-1827.2006.01942.x","article-title":"RET receptor signaling: dysfunction in thyroid cancer and Hirschsprung's disease","volume":"56","author":"Asai","year":"2006","journal-title":"Pathol Int"},{"issue":"12","key":"2023091509045933600_bnad009-B466","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1634\/theoncologist.2014-0277","article-title":"Epidemiology, clinical features, and genetics of multiple endocrine neoplasia type 2B in a complete population","volume":"19","author":"Znaczko","year":"2014","journal-title":"Oncologist"},{"issue":"3","key":"2023091509045933600_bnad009-B467","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/cen.14536","article-title":"Children with multiple endocrine neoplasia type 2B: Not tall and marfanoid, but short with normal body proportions","volume":"95","author":"van den Broek","year":"2021","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"3","key":"2023091509045933600_bnad009-B468","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1007\/s12020-021-02607-2","article-title":"Timely diagnosis of multiple endocrine neoplasia 2B by identification of intestinal ganglioneuromatosis: a case series","volume":"72","author":"van den Broek","year":"2021","journal-title":"Endocrine"},{"issue":"3","key":"2023091509045933600_bnad009-B469","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S2213-8587(18)30336-X","article-title":"Natural history, treatment, and long-term follow up of patients with multiple endocrine neoplasia type 2B: an international, multicentre, retrospective study","volume":"7","author":"Castinetti","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"2","key":"2023091509045933600_bnad009-B470","doi-asserted-by":"crossref","first-page":"89","DOI":"10.2217\/ije-2015-0008","article-title":"A patient with MEN1 typical features and MEN2-like features","volume":"3","author":"El-Maouche","year":"2016","journal-title":"Int J Endocr Oncol"},{"issue":"11","key":"2023091509045933600_bnad009-B471","first-page":"3048","article-title":"Recessive transmission of a multiple endocrine neoplasia syndrome in the rat","volume":"62","author":"Fritz","year":"2002","journal-title":"Cancer Res"},{"issue":"16","key":"2023091509045933600_bnad009-B472","doi-asserted-by":"crossref","first-page":"6147","DOI":"10.1128\/MCB.20.16.6147-6158.2000","article-title":"Functional collaboration between different cyclin-dependent kinase inhibitors suppresses tumor growth with distinct tissue specificity","volume":"20","author":"Franklin","year":"2000","journal-title":"Mol Cell Biol"},{"issue":"42","key":"2023091509045933600_bnad009-B473","doi-asserted-by":"crossref","first-page":"15558","DOI":"10.1073\/pnas.0603877103","article-title":"Germ-line mutations in p27Kip1 cause a multiple endocrine neoplasia syndrome in rats and humans","volume":"103","author":"Pellegata","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"2023091509045933600_bnad009-B474","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1006\/excr.2000.5143","article-title":"p27(Kip1): regulation and function of a haploinsufficient tumor suppressor and its misregulation in cancer","volume":"264","author":"Philipp-Staheli","year":"2001","journal-title":"Exp Cell Res"},{"issue":"5","key":"2023091509045933600_bnad009-B475","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/S0092-8674(00)81239-8","article-title":"A syndrome of multiorgan hyperplasia with features of gigantism, tumorigenesis, and female sterility in p27(Kip1)-deficient mice","volume":"85","author":"Fero","year":"1996","journal-title":"Cell"},{"issue":"6707","key":"2023091509045933600_bnad009-B476","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/24179","article-title":"The murine gene p27Kip1 is haplo-insufficient for tumour suppression","volume":"396","author":"Fero","year":"1998","journal-title":"Nature"},{"issue":"1","key":"2023091509045933600_bnad009-B477","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2796.2009.02108.x","article-title":"Multiple endocrine neoplasias: advances and challenges for the future","volume":"266","author":"Alevizaki","year":"2009","journal-title":"J Intern Med"},{"issue":"8","key":"2023091509045933600_bnad009-B478","doi-asserted-by":"crossref","first-page":"3321","DOI":"10.1210\/jc.2006-2843","article-title":"Germline CDKN1B\/p27Kip1 mutation in multiple endocrine neoplasia","volume":"92","author":"Georgitsi","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2023091509045933600_bnad009-B479","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1210\/jc.2008-2083","article-title":"Rare germline mutations in cyclin-dependent kinase inhibitor genes in multiple endocrine neoplasia type 1 and related states","volume":"94","author":"Agarwal","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"2023091509045933600_bnad009-B480","doi-asserted-by":"crossref","first-page":"E1825","DOI":"10.1002\/humu.21354","article-title":"A novel germline CDKN1B mutation causing multiple endocrine tumors: clinical, genetic and functional characterization","volume":"31","author":"Molatore","year":"2010","journal-title":"Human mutation"},{"key":"2023091509045933600_bnad009-B481","first-page":"510985","article-title":"Early Onset Primary Hyperparathyroidism Associated with a Novel Germline Mutation in CDKN1B","volume":"2015","author":"Elston","year":"2015","journal-title":"Case Rep Endocrinol"},{"issue":"10","key":"2023091509045933600_bnad009-B482","doi-asserted-by":"crossref","first-page":"T195","DOI":"10.1530\/ERC-17-0243","article-title":"MEN4 and CDKN1B mutations: the latest of the MEN syndromes","volume":"24","author":"Alrezk","year":"2017","journal-title":"Endocr Relat Cancer"},{"issue":"1","key":"2023091509045933600_bnad009-B483","doi-asserted-by":"crossref","first-page":"e220174","DOI":"10.1530\/ERC-22-0174","article-title":"Germline CDKN1B variant type and site are associated with phenotype in MEN4","volume":"30","author":"Halperin","year":"2023","journal-title":"Endocr Relat Cancer"},{"issue":"4","key":"2023091509045933600_bnad009-B484","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1210\/clinem\/dgaa957","article-title":"Multiple endocrine tumors associated with germline MAX mutations: multiple endocrine neoplasia type 5?","volume":"106","author":"Seabrook","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2023091509045933600_bnad009-B485","doi-asserted-by":"crossref","first-page":"829","DOI":"10.7326\/0003-4819-49-4-829","article-title":"Hereditary hyperparathyroidism associated with recurrent pancreatitis","volume":"49","author":"Jackson","year":"1958","journal-title":"Ann Intern Med"},{"issue":"6","key":"2023091509045933600_bnad009-B486","first-page":"1006","article-title":"Hereditary hyperparathyroidism and multiple ossifying jaw fibromas: a clinically and genetically distinct syndrome","volume":"108","author":"Jackson","year":"1990","journal-title":"Surgery"},{"issue":"5","key":"2023091509045933600_bnad009-B487","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1086\/340093","article-title":"Revised 14.7-cM locus for the hyperparathyroidism-jaw tumor syndrome gene, HRPT2","volume":"70","author":"Hobbs","year":"2002","journal-title":"Am J Hum Genet"},{"issue":"12","key":"2023091509045933600_bnad009-B488","first-page":"4204","article-title":"Autosomal dominant primary hyperparathyroidism and jaw tumor syndrome associated with renal hamartomas and cystic kidney disease: linkage to 1q21-q32 and loss of the wild type allele in renal hamartomas","volume":"81","author":"Teh","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2023091509045933600_bnad009-B489","first-page":"944","article-title":"Hereditary hyperparathyroidism-jaw tumor syndrome: the endocrine tumor gene HRPT2 maps to chromosome 1q21-q31","volume":"56","author":"Szabo","year":"1995","journal-title":"Am J Hum Genet"},{"issue":"4","key":"2023091509045933600_bnad009-B490","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/ng1048","article-title":"HRPT2, encoding parafibromin, is mutated in hyperparathyroidism-jaw tumor syndrome","volume":"32","author":"Carpten","year":"2002","journal-title":"Nat Genet"},{"issue":"4","key":"2023091509045933600_bnad009-B491","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.ijom.2006.08.007","article-title":"A case of hyperparathyroidism-jaw tumour syndrome found in the treatment of an ossifying fibroma in the maxillary bone","volume":"36","author":"Yamashita","year":"2007","journal-title":"Int J Oral Maxillofac Surg"},{"issue":"3","key":"2023091509045933600_bnad009-B492","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/j.1365-2265.2006.02460.x","article-title":"Parafibromin mutations in hereditary hyperparathyroidism syndromes and parathyroid tumours","volume":"64","author":"Bradley","year":"2006","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"4","key":"2023091509045933600_bnad009-B493","doi-asserted-by":"crossref","first-page":"602","DOI":"10.4158\/EP10337.RA","article-title":"Familial hyperparathyroidism due to a germline mutation of the CDC73 gene: implications for management and age-appropriate testing of relatives at risk","volume":"17","author":"Pichardo-Lowden","year":"2011","journal-title":"Endocr Pract"},{"issue":"3","key":"2023091509045933600_bnad009-B494","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1530\/EJE-11-0003","article-title":"CDC73-related hereditary hyperparathyroidism: five new mutations and the clinical spectrum","volume":"165","author":"Frank-Raue","year":"2011","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"2023091509045933600_bnad009-B495","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1007\/s00423-009-0511-y","article-title":"Hyperparathyroidism-jaw tumor syndrome: a report of three large kindred","volume":"394","author":"Iacobone","year":"2009","journal-title":"Langenbecks Arch Surg"},{"issue":"2","key":"2023091509045933600_bnad009-B496","doi-asserted-by":"crossref","first-page":"E403","DOI":"10.1210\/jc.2012-2789","article-title":"Frequent large germline HRPT2 deletions in a French national cohort of patients with primary hyperparathyroidism","volume":"98","author":"Bricaire","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"2023091509045933600_bnad009-B497","doi-asserted-by":"crossref","first-page":"4534","DOI":"10.1210\/jc.2017-01249","article-title":"CDC73-related disorders: clinical manifestations and case detection in primary hyperparathyroidism","volume":"102","author":"van der Tuin","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"2023091509045933600_bnad009-B498","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/j.1365-2796.2004.01421.x","article-title":"Uterine tumours are a phenotypic manifestation of the hyperparathyroidism-jaw tumor syndrome","volume":"257","author":"Bradley","year":"2005","journal-title":"J Inter Med"},{"issue":"11","key":"2023091509045933600_bnad009-B499","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1002\/gcc.20911","article-title":"Detection of the first gross CDC73 germline deletion in an HPT-JT syndrome family","volume":"50","author":"Casc\u00f3n","year":"2011","journal-title":"Genes Chromosomes Cancer"},{"issue":"2","key":"2023091509045933600_bnad009-B500","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1007\/s00268-019-05156-y","article-title":"Long-term outcomes of parathyroidectomy in hyperparathyroidism-jaw tumor syndrome: analysis of five families with CDC73 mutations","volume":"44","author":"Iacobone","year":"2020","journal-title":"World J Surg"},{"issue":"8","key":"2023091509045933600_bnad009-B501","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1007\/s00423-015-1342-7","article-title":"Hereditary hyperparathyroidism-a consensus report of the European Society of Endocrine Surgeons (ESES)","volume":"400","author":"Iacobone","year":"2015","journal-title":"Langenbecks Arch Surg"},{"issue":"1","key":"2023091509045933600_bnad009-B502","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/PAS.0000000000001017","article-title":"Parafibromin-deficient (HPT-JT Type, CDC73 mutated) parathyroid tumors demonstrate distinctive morphologic features","volume":"43","author":"Gill","year":"2019","journal-title":"Am J Surg Pathol"},{"issue":"26","key":"2023091509045933600_bnad009-B503","doi-asserted-by":"crossref","first-page":"5070","DOI":"10.1016\/j.febslet.2007.09.050","article-title":"Nucleolar localization of parafibromin is mediated by three nucleolar localization signals","volume":"581","author":"Hahn","year":"2007","journal-title":"FEBS Lett"},{"issue":"1","key":"2023091509045933600_bnad009-B504","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s00428-010-1032-3","article-title":"Absence of nucleolar parafibromin immunoreactivity in subsets of parathyroid malignant tumours","volume":"459","author":"Juhlin","year":"2011","journal-title":"Virchows Arch"},{"issue":"11","key":"2023091509045933600_bnad009-B505","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1080\/15384047.2015.1070989","article-title":"Non-functional parathyroid carcinoma: a case report and review of the literature","volume":"16","author":"Wang","year":"2015","journal-title":"Cancer Biol Ther"},{"issue":"9","key":"2023091509045933600_bnad009-B506","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1530\/ERC-20-0149","article-title":"Genotype of CDC73 germline mutation determines risk of parathyroid cancer","volume":"27","author":"Li","year":"2020","journal-title":"Endocr Relat Cancer"},{"issue":"1","key":"2023091509045933600_bnad009-B507","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s12105-017-0794-1","article-title":"Update from the 4th edition of the World Health Organization classification of head and neck tumours: odontogenic and maxillofacial bone tumors","volume":"11","author":"Wright","year":"2017","journal-title":"Head Neck Pathol"},{"key":"2023091509045933600_bnad009-B508","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/1746-1596-9-75","article-title":"Two cases of multiple ossifying fibromas in the jaws","volume":"9","author":"Wang","year":"2014","journal-title":"Diagn Pathol"},{"issue":"1","key":"2023091509045933600_bnad009-B509","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1259\/dmfr\/96330046","article-title":"Ossifying fibromas of the jaw bone: 20 cases","volume":"39","author":"Liu","year":"2010","journal-title":"Dentomaxillofac Radiol"},{"key":"2023091509045933600_bnad009-B510","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ijscr.2018.09.035","article-title":"Jaw tumor in recurrent primary hyperparathyroidism: a case report","volume":"52","author":"Nezhad F","year":"2018","journal-title":"Int J Surg Case Rep"},{"issue":"6","key":"2023091509045933600_bnad009-B511","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1007\/s13244-016-0519-0","article-title":"Hyperparathyroidism jaw tumour syndrome: a pictoral review","volume":"7","author":"du Preez","year":"2016","journal-title":"Insights Imaging"},{"issue":"2","key":"2023091509045933600_bnad009-B512","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1007\/s12022-016-9427-6","article-title":"A novel mutation in a patient with hyperparathyroidism-jaw tumour syndrome","volume":"27","author":"Bellido","year":"2016","journal-title":"Endocr Pathol"},{"issue":"1","key":"2023091509045933600_bnad009-B513","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s13000-016-0532-0","article-title":"CDC73 gene mutations in sporadic ossifying fibroma of the jaws","volume":"11","author":"Chen","year":"2016","journal-title":"Diagn Pathol"},{"issue":"7","key":"2023091509045933600_bnad009-B514","doi-asserted-by":"crossref","first-page":"bvab087","DOI":"10.1210\/jendso\/bvab087","article-title":"Parafibromin abnormalities in ossifying fibroma","volume":"5","author":"Costa-Guda","year":"2021","journal-title":"J Endocr Soc"},{"issue":"7","key":"2023091509045933600_bnad009-B515","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.oraloncology.2005.11.019","article-title":"HRPT2 gene alterations in ossifying fibroma of the jaws","volume":"42","author":"Pimenta","year":"2006","journal-title":"Oral Oncol"},{"issue":"6","key":"2023091509045933600_bnad009-B516","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1016\/j.fertnstert.2012.08.017","article-title":"Aromatase inhibitor treatment of menorrhagia and subsequent pregnancy in a patient with familial hyperparathyroidism-jaw tumor syndrome","volume":"98","author":"Wolff","year":"2012","journal-title":"Fertil Steril"},{"issue":"3","key":"2023091509045933600_bnad009-B517","doi-asserted-by":"crossref","first-page":"e222","DOI":"10.4158\/ACCR-2018-0555","article-title":"Ovarian granulosa cell tumor in a patient with a pathogenic variant in the cdc73 gene (hyperparathyroidism-jaw tumor syndrome)","volume":"5","author":"Sirbiladze","year":"2019","journal-title":"AACE Clin Case Rep"},{"key":"2023091509045933600_bnad009-B518","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.urology.2018.11.013","article-title":"CDC73 germline mutation in a family with mixed epithelial and stromal tumors","volume":"124","author":"Vocke","year":"2019","journal-title":"Urology"},{"key":"2023091509045933600_bnad009-B519","first-page":"9298147","article-title":"Hyperparathyroidism jaw tumor syndrome presenting as recurrent femur fractures in a young woman; a rare presentation of a rare disease","volume":"2020","author":"Wijewickrama","year":"2020","journal-title":"Case Rep Endocrinol"},{"issue":"23","key":"2023091509045933600_bnad009-B520","doi-asserted-by":"crossref","first-page":"3440","DOI":"10.1038\/sj.onc.1210131","article-title":"Sporadic human renal tumors display frequent allelic imbalances and novel mutations of the HRPT2 gene","volume":"26","author":"Zhao","year":"2007","journal-title":"Oncogene"},{"issue":"9","key":"2023091509045933600_bnad009-B521","doi-asserted-by":"crossref","first-page":"3044","DOI":"10.1210\/jc.2014-1481","article-title":"CDC73 intragenic deletion in familial primary hyperparathyroidism associated with parathyroid carcinoma","volume":"99","author":"Korpi-Hy\u00f6v\u00e4lti","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"2023091509045933600_bnad009-B522","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1186\/1471-2407-10-196","article-title":"Genomic expression and single-nucleotide polymorphism profiling discriminates chromophobe renal cell carcinoma and oncocytoma","volume":"10","author":"Tan","year":"2010","journal-title":"BMC Cancer"},{"issue":"2","key":"2023091509045933600_bnad009-B523","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s00428-007-0551-z","article-title":"Downregulated parafibromin expression is a promising marker for pathogenesis, invasion, metastasis and prognosis of gastric carcinomas","volume":"452","author":"Zheng","year":"2008","journal-title":"Virchows Arch"},{"issue":"1","key":"2023091509045933600_bnad009-B524","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1136\/jcp.2007.048694","article-title":"Parafibromin expression in breast cancer: a novel marker for prognostication?","volume":"61","author":"Selvarajan","year":"2008","journal-title":"J Clin Pathol"},{"issue":"9","key":"2023091509045933600_bnad009-B525","doi-asserted-by":"crossref","first-page":"2930","DOI":"10.1128\/MCB.00654-07","article-title":"Parafibromin, a component of the human PAF complex, regulates growth factors and is required for embryonic development and survival in adult mice","volume":"28","author":"Wang","year":"2008","journal-title":"Mol Cell Biol"},{"issue":"18","key":"2023091509045933600_bnad009-B526","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1056\/NEJMp038159","article-title":"HRPT2, a marker of parathyroid cancer","volume":"349","author":"Weinstein","year":"2003","journal-title":"N Engl J Med"},{"issue":"6","key":"2023091509045933600_bnad009-B527","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/S0022-3476(72)80232-4","article-title":"Familial benign hypercalcemia","volume":"81","author":"Foley TP","year":"1972","journal-title":"J Pediatr"},{"issue":"4","key":"2023091509045933600_bnad009-B528","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1007\/s002230001201","article-title":"The prevalence of familial hypocalciuric hypercalcemia","volume":"68","author":"Hinnie","year":"2001","journal-title":"Calcif Tissue Int"},{"issue":"1","key":"2023091509045933600_bnad009-B529","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/jbmr.3339","article-title":"Familial hypocalciuric hypercalcemia as an atypical form of primary Hyperparathyroidism","volume":"33","author":"Marx","year":"2018","journal-title":"J Bone Miner Res"},{"issue":"2","key":"2023091509045933600_bnad009-B530","doi-asserted-by":"crossref","first-page":"L29","DOI":"10.1210\/jc.2014-4221","article-title":"Letter to the editor: Distinguishing typical primary hyperparathyroidism from familial hypocalciuric hypercalcemia by using an index of urinary calcium","volume":"100","author":"Marx","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"2023091509045933600_bnad009-B531","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1210\/jc.2017-02773","article-title":"Pro-FHH: a risk equation to facilitate the diagnosis of parathyroid-related hypercalcemia","volume":"103","author":"Bertocchio","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2023091509045933600_bnad009-B532","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1210\/jcem.87.3.8304","article-title":"Parathyroid adenoma in a subject with familial hypocalciuric hypercalcemia: coincidence or causality?","volume":"87","author":"Burski","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2023091509045933600_bnad009-B533","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.beem.2018.05.004","article-title":"Familial hypocalciuric hypercalcemia and related disorders","volume":"32","author":"Lee","year":"2018","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"1","key":"2023091509045933600_bnad009-B534","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s12902-021-00683-z","article-title":"Misleading localization by 18F-fluorocholine PET\/CT in familial hypocalciuric hypercalcemia type-3: a case report","volume":"21","author":"Mukhtar","year":"2021","journal-title":"BMC Endocr Disord"},{"issue":"9","key":"2023091509045933600_bnad009-B535","doi-asserted-by":"crossref","first-page":"E1721","DOI":"10.1210\/jc.2014-1541","article-title":"Cardiometabolic phenotyping of patients with familial hypocalcuric hypercalcemia","volume":"99","author":"Wolf","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2023091509045933600_bnad009-B536","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1530\/EJE-16-0369","article-title":"The cardiovascular system in familial hypocalciuric hypercalcemia: a cross-sectional study on physiological effects of inactivating variants in the calcium-sensing receptor gene","volume":"175","author":"Jakobsen NF","year":"2016","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"2023091509045933600_bnad009-B537","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/ng1295-389","article-title":"A mouse model of human familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism","volume":"11","author":"Ho","year":"1995","journal-title":"Nat Genet"},{"issue":"18","key":"2023091509045933600_bnad009-B538","doi-asserted-by":"crossref","first-page":"5079","DOI":"10.1093\/hmg\/ddv226","article-title":"Adaptor protein-2 sigma subunit mutations causing familial hypocalciuric hypercalcaemia type 3 (FHH3) demonstrate genotype-phenotype correlations, codon bias and dominant-negative effects","volume":"24","author":"Hannan","year":"2015","journal-title":"Hum Mol Genet"},{"issue":"10","key":"2023091509045933600_bnad009-B539","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1093\/hmg\/ddab076","article-title":"Ap2s1 mutation causes hypercalcaemia in mice and impairs interaction between calcium-sensing receptor and adaptor protein-2","volume":"30","author":"Hannan","year":"2021","journal-title":"Hum Mol Genet"},{"issue":"3","key":"2023091509045933600_bnad009-B540","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1172\/JCI117062","article-title":"Familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Effects of mutant gene dosage on phenotype","volume":"93","author":"Pollak","year":"1994","journal-title":"J Clin Invest"},{"issue":"4","key":"2023091509045933600_bnad009-B541","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1210\/clinem\/dgz233","article-title":"Neonatal severe hyperparathyroidism: novel insights from Calcium, PTH, and the CASR Gene","volume":"105","author":"Marx","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2023091509045933600_bnad009-B542","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.jpedsurg.2009.08.005","article-title":"Surgical management of severe neonatal hyperparathyroidism: 1 center's experience","volume":"45","author":"Al-Shanafey","year":"2010","journal-title":"J Pediatr Surg"},{"key":"2023091509045933600_bnad009-B543","first-page":"150040","article-title":"Successful treatment of neonatal severe hyperparathyroidism with cinacalcet in two patients","volume":"2015","author":"Fisher","year":"2015","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"issue":"1","key":"2023091509045933600_bnad009-B544","doi-asserted-by":"crossref","first-page":"e0210662","DOI":"10.1371\/journal.pone.0210662","article-title":"Gcm2 regulates the maintenance of parathyroid cells in adult mice","volume":"14","author":"Yamada","year":"2019","journal-title":"PLoS One"},{"issue":"8","key":"2023091509045933600_bnad009-B545","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1172\/JCI200113180","article-title":"Familial isolated hypoparathyroidism caused by a mutation in the gene for the transcription factor GCMB","volume":"108","author":"Ding","year":"2001","journal-title":"J Clin Invest"},{"issue":"1","key":"2023091509045933600_bnad009-B546","doi-asserted-by":"crossref","first-page":"2968","DOI":"10.1038\/s41598-021-82661-y","article-title":"Five patients with disorders of calcium metabolism presented with GCM2 gene variants","volume":"11","author":"Garc\u00eda-Casta\u00f1o","year":"2021","journal-title":"Sci Rep"},{"issue":"5","key":"2023091509045933600_bnad009-B547","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1210\/js.2017-00043","article-title":"Ethnicity of patients with germline GCM2-activating variants and primary hyperparathyroidism","volume":"1","author":"Guan","year":"2017","journal-title":"J Endocr Soc"},{"issue":"12","key":"2023091509045933600_bnad009-B548","doi-asserted-by":"crossref","first-page":"E2794","DOI":"10.1210\/jc.2014-2857","article-title":"Increased prevalence of the GCM2 polymorphism, Y282D, in primary hyperparathyroidism: analysis of three Italian cohorts","volume":"99","author":"D'Agruma","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2023091509045933600_bnad009-B549","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1210\/jc.2018-02517","article-title":"Analysis of activating GCM2 sequence variants in sporadic parathyroid adenomas","volume":"104","author":"Riccardi","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2023091509045933600_bnad009-B550","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1530\/EJE-19-0641","article-title":"Should the GCM2 gene be tested when screening for familial primary hyperparathyroidism?","volume":"182","author":"Coppin","year":"2020","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"2023091509045933600_bnad009-B551","doi-asserted-by":"crossref","first-page":"e2021","DOI":"10.1210\/clinem\/dgab929","article-title":"GCM2 Variants in familial and multiglandular primary hyperparathyroidism","volume":"107","author":"Vincze","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2023091509045933600_bnad009-B552","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.surg.2017.04.027","article-title":"Familial isolated primary hyperparathyroidism associated with germline GCM2 mutations is more aggressive and has a lesser rate of biochemical cure","volume":"163","author":"Lakis M","year":"2018","journal-title":"Surgery"},{"issue":"10","key":"2023091509045933600_bnad009-B553","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.4158\/EP-2020-0132","article-title":"Germline GCM2 Mutation Screening in Chinese Primary Hyperparathyroidism Patients","volume":"26","author":"Song","year":"2020","journal-title":"Endocr Pract"},{"issue":"3","key":"2023091509045933600_bnad009-B554","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1007\/BF03401311","article-title":"Familial isolated primary hyperparathyroidism due to HRPT2 mutation","volume":"12","author":"Ghemigian","year":"2013","journal-title":"Hormones (Athens)"},{"issue":"2","key":"2023091509045933600_bnad009-B555","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/cen.12461","article-title":"Familial isolated primary hyperparathyroidism\/hyperparathyroidism-jaw tumour syndrome caused by germline gross deletion or point mutations of CDC73 gene in Chinese","volume":"81","author":"Kong","year":"2014","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"8","key":"2023091509045933600_bnad009-B556","first-page":"470","article-title":"Familial isolated hyperparathyroidism due to HRPT2 mutation","volume":"65","author":"Luj\u00e1n","year":"2018","journal-title":"Endocrinol Diabetes Nutr (Engl Ed)"},{"issue":"4","key":"2023091509045933600_bnad009-B557","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s00774-013-0551-9","article-title":"Genetic basis of familial isolated hyperparathyroidism: a case series and a narrative review of the literature","volume":"32","author":"Pontikides","year":"2014","journal-title":"J Bone Miner Metab"},{"issue":"9","key":"2023091509045933600_bnad009-B558","doi-asserted-by":"crossref","first-page":"4058","DOI":"10.1210\/jc.2018-02789","article-title":"New Concepts About Familial Isolated Hyperparathyroidism","volume":"104","author":"Marx","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2023091509045933600_bnad009-B559","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s40618-019-01107-5","article-title":"Whole exome sequencing in familial isolated primary hyperparathyroidism","volume":"43","author":"Cetani","year":"2020","journal-title":"J Endocrinol Invest"},{"issue":"1","key":"2023091509045933600_bnad009-B560","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.surg.2022.07.057","article-title":"A multicenter evaluation of near-infrared autofluorescence imaging of parathyroid glands in thyroid and parathyroid surgery","volume":"173","author":"Sehnem L","year":"2023","journal-title":"Surgery"},{"issue":"3","key":"2023091509045933600_bnad009-B561","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1210\/jc.2018-01104","article-title":"Primary hyperparathyroidism in pregnancy: maternofetal outcomes at a quaternary referral obstetric hospital, 2000 through 2015","volume":"104","author":"Rigg","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2023091509045933600_bnad009-B562","doi-asserted-by":"crossref","first-page":"bvac027","DOI":"10.1210\/jendso\/bvac027","article-title":"Parathyroid hormone regulates circulating levels of Sclerostin and FGF23 in a primary hyperparathyroidism model","volume":"6","author":"Nagata","year":"2022","journal-title":"J Endocr Soc"},{"issue":"1","key":"2023091509045933600_bnad009-B563","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.surg.2015.06.057","article-title":"FGF23, metabolic risk factors, and blood pressure in patients with primary hyperparathyroidism undergoing parathyroid adenomectomy","volume":"159","author":"Nilsson","year":"2016","journal-title":"Surgery"},{"issue":"1","key":"2023091509045933600_bnad009-B564","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1530\/EJE-11-0523","article-title":"Increased circulating levels of FGF23: an adaptive response in primary hyperparathyroidism?","volume":"166","author":"Witteveen","year":"2012","journal-title":"Eur J Endocrinol"},{"issue":"7","key":"2023091509045933600_bnad009-B565","doi-asserted-by":"crossref","first-page":"3413","DOI":"10.1210\/jc.2003-031911","article-title":"Hormonal and biochemical normalization and tumor shrinkage induced by anti-parathyroid hormone immunotherapy in a patient with metastatic parathyroid carcinoma","volume":"89","author":"Betea","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"2023091509045933600_bnad009-B566","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1002\/jbmr.4677","article-title":"International workshop on primary H. Evaluation and management of primary hyperparathyroidism: summary statement and guidelines from the fifth international workshop","volume":"37","author":"Bilezikian","year":"2022","journal-title":"J Bone Miner Res"},{"issue":"1","key":"2023091509045933600_bnad009-B567","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/cen.14112","article-title":"Single gland excision for MEN1-associated primary hyperparathyroidism","volume":"92","author":"Manoharan","year":"2020","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"12","key":"2023091509045933600_bnad009-B568","doi-asserted-by":"crossref","first-page":"3302","DOI":"10.1210\/clinem\/dgac527","article-title":"Identification of 4 new loci associated With Primary Hyperparathyroidism (PHPT) and a Polygenic risk score for PHPT","volume":"107","author":"Soto-Pedre","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2023091509045933600_bnad009-B569","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/cen.14254","article-title":"Genetic testing for hereditary hyperparathyroidism and familial hypocalciuric hypercalcaemia in a large UK cohort","volume":"93","author":"Mariathasan","year":"2020","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"5","key":"2023091509045933600_bnad009-B570","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.jamcollsurg.2018.01.007","article-title":"Probability of positive genetic testing results in patients with family history of primary hyperparathyroidism","volume":"226","author":"Lakis M","year":"2018","journal-title":"J Am Coll Surg"},{"issue":"6","key":"2023091509045933600_bnad009-B571","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1111\/joim.12523","article-title":"Genetics of parathyroid tumours","volume":"280","author":"Thakker","year":"2016","journal-title":"J Intern Med"},{"issue":"1-2","key":"2023091509045933600_bnad009-B572","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/s12672-011-0100-8","article-title":"Frequent germ-line mutations of the MEN1, CASR, and HRPT2\/CDC73 genes in young patients with clinically non-familial primary hyperparathyroidism","volume":"3","author":"Starker","year":"2012","journal-title":"Horm Cancer"},{"key":"2023091509045933600_bnad009-B573","doi-asserted-by":"crossref","DOI":"10.1111\/cen.14659","article-title":"Primary hyperparathyroidism in adults-(Part I) assessment and medical management: position statement of the Endocrine Society of Australia, the Australian & New Zealand Endocrine Surgeons, and the Australian & New Zealand Bone and Mineral Society","author":"Milat","year":"2021","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"2023091509045933600_bnad009-B574","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00198-016-3716-2","article-title":"Primary hyperparathyroidism: review and recommendations on evaluation, diagnosis, and management. A Canadian and international consensus","volume":"28","author":"Khan","year":"2017","journal-title":"Osteoporos Int"},{"issue":"10","key":"2023091509045933600_bnad009-B575","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1001\/jamasurg.2016.2310","article-title":"The American Association of Endocrine Surgeons guidelines for definitive management of primary hyperparathyroidism","volume":"151","author":"Wilhelm","year":"2016","journal-title":"JAMA Surg"}],"container-title":["Endocrine Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/edrv\/advance-article-pdf\/doi\/10.1210\/endrev\/bnad009\/50034030\/bnad009.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/edrv\/article-pdf\/44\/5\/779\/51558902\/bnad009.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/edrv\/article-pdf\/44\/5\/779\/51558902\/bnad009.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,9]],"date-time":"2023-12-09T15:39:38Z","timestamp":1702136378000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/edrv\/article\/44\/5\/779\/7085685"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,24]]},"references-count":575,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2023,3,24]]},"published-print":{"date-parts":[[2023,9,15]]}},"URL":"https:\/\/doi.org\/10.1210\/endrev\/bnad009","relation":{},"ISSN":["0163-769X","1945-7189"],"issn-type":[{"value":"0163-769X","type":"print"},{"value":"1945-7189","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,10]]},"published":{"date-parts":[[2023,3,24]]}}}